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ROS are oxygen - derived small molecules. The initial form of ROS is superoxide anion (O2.-
) which is produced by the gain of electrons. Subsequent chemical reactions can lead to the 
formation of other forms of ROS species. NOX enzymes are one of the major sources of 
ROS. NOX5 belongs to the family of NOX enzymes.  NOX5 differs from the other members 
of the NOX family in aspects as such as its mode of activation and biophysical structure. 
NOX5 comprises of 2 membrane-bound subunits namely gp91 and p22. It does not require 
the recruitment of cytosolic subunits, unlike its counterparts. The activity of NOX5 is 
regulated by elevations in cytosolic calcium levels and phosphorylation via kinases such as c-
Abl (Abelson murine leukemia viral oncogene) and PKC. The N-terminus of NOX5 
comprises EF-hands that serve as calcium binding domains. It has been established so far that 
NOX5 is a growth signalling oxidase and its expression is regulated via growth regulatory 
agonists/triggers/signals. NOX5 has been also shown to be expressed in a variety of tumour 
cell lines and is being explored as a cancer biomarker. RSV a naturally occurring phenolic 
phytoalexin is currently being employed as a ‘parent’ compound in cancer drug development. 
It has been well-studied that RSV is a ROS-modulating compound. It can act as a pro/anti-
oxidant depending on the concentration and cell line used. Previous studies have shown that, 
RSV is able to alter the expression and activity of other NOX isoforms is a range of cell lines. 
This study aimed to investigate the involvement of RSV-induced ROS production in 
regulating NOX5 expression in the U937 lymphoma cells.  The initial part of the study 
involved analyzing the expression of NOX5 following RSV treatment. RSV was shown to 
increase NOX5 expression in U937 in a dose-dependent manner. A time course was also 
performed and it showed that NOX5 expression starts to increase as early as 2hr. ROS was 
being implicated as the possible factor involved in the regulation of NOX5 expression due to 
the nature of RSV. The pre-treatment of U937 with ROS scavengers prior to RSV treatment 
abrogated the increase in NOX5 expression. Further studies were performed and it showed 
ROS producing compounds such as DDC and H2O2 were able to increase NOX5 expression 
level. However, NO-producing compounds did not significantly alter the NOX5 expression 
level. CREB phosphorylation was observed post-RSV treatment and this was reversible via 
pre-incubation with Cyclosporin A. CREB phosphorylation levels were also observed to 
precede the increase NOX5 expression level. Thus CREB is being suggested as a possible 
transcription factor regulating NOX5 expression. This study highlights the role of ROS 
producing compound RSV in regulating the expression level of NOX5 in U937.  (442 words) 
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1.1 (a):  Reactive oxygen species (ROS) 
 
Oxygen is one of the most abundant gases in the atmosphere and is the principle 
component in air. Dry air contains roughly (by volume) 78.09% nitrogen, 20.95% 
oxygen, 0.93% argon, 0.039% carbon dioxide, and small amounts of other gases. Air also 
contains a variable amount of water vapor (an average of 1%). Reactive oxygen species 
(ROS) are oxygen-derived small molecules (Bedard and Krause, 2007). These comprise 
of free radicals (i.e., species with ≥ 1 unpaired electrons) such as superoxide anion (O2.-), 
peroxynitrite (ONOO-), hydroxyl (OH-), peroxyl (RO2-) and alkoxyl (RO-) and some non- 
radical species such as hydrogen peroxide (H2O2), ozone (O3) and hypochlorous acid 
(HOCl)(Lambeth, 2004). ROS has been under intense investigation for its role in cellular 
‘Oxidative stress’. ‘Oxidative stress’ is best described as the imbalance between oxidants 
and antioxidants, in favor of oxidants, potentially leading to damage (Sies, 1991). 
Interestingly, the various ROS species differ in their reactivity with O2.- and H2O2 being 
weaker and displaying limited bioreactivity in comparison to ONOO-, OH- and HOCl 
(Halliwell, 2006). These species can be grouped according to their redox potentials at pH 
7. Most ROS reactions are not based on electron transfer but rather proton coupled 
electron transfer (PCET) e.g., conversion of H2O2 to O2 and H2O. ROS generation begins 
with the generation of O2.-. O2.- is a short-lived molecule and undergoes spontaneous 
dismutation to O2 and H2O2 at the rate of 105M-1S-1 at pH7. It can also be rapidly 
converted to other forms of ROS; 1) O2.- can be converted to OH- by the Fenton reaction, 
2) react with nitric oxide (NO) to form ONOO- 3) form H2O2 in a reaction generally 
catalysed by superoxide dismutase (SOD) (D'Autréaux and Toledano, 2007). The essence 
of these biochemical processes involving the progressive formation of ROS from O2.-  is 
illustrated in Figure 2. 
 












Figure 1: The main biochemical reactions involved in the formation of ROS.  
The diagram illustrates the progressive formation of the various ROS species with O2.- as the initial 
specie formed. The redox potentials of each ROS forming stage are also highlighted 
 
Adapted from: D’Autréaux and Michel B. Toledano 
Nature Reviews, Molecular Cell Biology 2007 
ROS are produced in response to growth factors, cytokines, G protein-coupled receptor 
agonists, or shear stress and have been well-characterized to mediate various responses 
including cell proliferation, migration, differentiation and gene expression (Bedard and 
Krause, 2007; Brown and Griendling, 2009). A number of studies have shown that ROS  
has both positive and detrimental impacts in cellular physiology. This is as, ROS can 
react with cellular components such as lipids, proteins and nucleic acids.  As stated 
previously, an imbalance in the redox status of the cell leads to the physiological 
condition termed, ‘oxidative stress’. This condition has been linked to be involved in a 
number of disease states such as Alzheimer’s, arthritis and cancer due to the disruption of 
cell death and proliferation mechanisms (Azad et al., 2008; Halliwell, 2007; Pervaiz and 
Clement, 2007).  
 
In the cell, there are a number of enzyme-based systems that generate ROS, NADPH 





(Bedard and Krause, 2007; Lambeth et al., 2007). The mitochondrial electron transport 
chain is another abundant source of ROS. The mitochondrial electron transport chain 
comprises of a chain of enzymes. Due to the electron leakage that occurs along the 
electron transport chain during these redox reactions, O2.- is generated. The other enzyme 
systems involved are xanthine oxidase, cyclooxygenase, lipooxygenase, cytochrome 
P450s, NOS (nitric oxide synthase) enzymes, other hemoproteins (Cai et al., 2003; 
Halliwell, 2007) as well as a number of antioxidant systems that protect the cell from 
potentially harmful effects such as the catalase, SODs and glutathione (GSH) system. The 
next section discusses the role of ROS as signaling molecules and the importance of a 
homeostatic redox environment in the cell.  
 
1.1(b) ROS as signaling molecules 
 
(i) Cell signaling fate resulting from the alteration of cellular redox status 
Current studies have well-established that a shift in the balance of ROS species present 
alters the signaling fate of the cell (Brown and Griendling, 2009; D'Autréaux and 
Toledano, 2007; Pervaiz and Clement, 2007). In the context of tumor biology it has been 
shown that an increase in the level of O2.- in comparison to H2O2 levels, promotes 
proliferation/survival and activation of cell survival signaling (Pervaiz and Clement, 
2007). However in contrast, when H2O2 levels are high  relative to superoxide levels, cell 
death signaling pathways predominate in the cell (Pervaiz and Clement, 2007). More 
specifically, millimolar concentrations of H2O2 result in necrotic cell death whereas 
micromolar concentrations of more than 80-100 seem to predominantly activate apoptotic 
signaling pathways. This elegant model is well illustrated in Figure 2 and it highlights the 










(ii) The antioxidant enzyme systems as a means of maintaining homeostatic cellular 
redox balance. 
As stated in the previous section, ROS is a product of normal cellular metabolism. The 
redox state of a cell is maintained and determined by the levels of pro-oxidant species 
like ROS and presence of antioxidant systems (Halliwell, 2007; Pervaiz and Clement, 
2007). Some of the antioxidant systems present are SOD 1-3 (Superoxide dismutases), 
Catalase, Thioredoxins/Peroxiredoxins and Glutathione peroxidase/reductase (Halliwell, 
2006). These antioxidant systems function as cellular protective mechanisms and provide 
the first line of defense against ROS.  
 
Superoxide dismutases (SODs) are involved in the scavenging of O2.-. SODs catalyze the 
conversion of superoxide anions into H2O2 and O2. The different forms of SODs vary in 
terms of their sub-cellular localization and the metal group present at the catalytic active 
site. SOD 1 or Cu/ZnSOD (Copper/Zinc SOD) is found in the cytosol and contains 
Copper and Zinc metal ions in the active site. SOD 2 commonly referred to as MnSOD 
(Manganese SOD) is localized in the mitochondria and its catalytic active site contains 
Manganese ion. SOD 3 is known as the extracellular SOD and contains copper and zinc 
at the active site.  In relation to cancer development, MnSOD is of specific interest in 
comparison to the other SODs. MnSOD has been found to be downregulated in certain 
tumor types (Valko et al., 2007). It has been studied that overexpression or increased 
activity of MnSOD leads to a decrease in the O2.- levels and subsequent suppression of 
cell growth in cancer lines (Valko et al., 2007). 
 
Catalase serves as the enzyme essential in the removal of H2O2 via its catalytic 
conversion into water and oxygen. The basic structure of catalase is a tetramer made up 
of 4 polypeptide chains. Each polypeptide contains a porphyrin heme group at the 
catalytic site involved in the reaction with hydrogen peroxide.  
 
Glutathione peroxidases (GPx) are a group of selenium-containing enzymes involved in 
the removal of H2O2 via the coupling of its reduction to the oxidation of glutathione 





made up of 2 GSH molecules linked by a disulphide bridge. GSSG can be converted to 
the reduced form GSH, via the action of glutathione reductases. Glutathione functions as 
an antioxidant molecule by protecting the cells against oxidative stress (Valko et al., 
2007). It performs this significant role by; 1. It regenerates most antioxidant enzymes 
such as Vitamin E and C, 2. GSH scavenges OH- and detoxifies H2O2, 3. It is present as a 
cofactor of several detoxifying enzymes such as GPx and 4. It participates in amino acid 
transport through the plasma membrane protecting them from oxidation. 
 
Peroxiredoxins (PrX) form another another group of enzymes that are involved in the 
decomposition of H2O2. PrXs are homodimers that contain cysteine (Cys) at their active 
groups. H2O2 oxidizes the SH group on PrX to form sulfeinc acid (Cys-SOH) and itself 
will be reduced to H2O and O2. The diagram in Figure 3 summarizes the intracellular 
sources of ROS and the various cellular antioxidant defense systems present. 
 
As mentioned previously, the NOX family of enzymes, function as one of the major 
contributing sources of ROS. This literature summarizes their activity and physiological 


















Figure 2: Diagram illustrating the importance of cellular homeostatic redox balance 
The diagram highlights the concept that O2.-  functions as a tumor-promoting ROS and H2O2 plays the 
converse role and promotes cell death. Thus a balance in the 2 types of ROS is essential in maintaining 
normal cellular function. 
Adapted from: Pervaiz, Clement, Int. J. Biochem & Cell biology 2007 
 
 Figure 3: The intracellular sources of ROS 
The subcellular compartmentalization of ROS 
Adapted from: Trachootham et.al 
Nature reviews Drug discovery 2009 
 







1.2:  NADPH Oxidases 
 
(i) Overview 
NADPH Oxidases or NOXs, are enzymes whose principal biological function is the 
production of the O2.- species (Bedard and Krause, 2007; Lambeth et al., 2007; Lambeth 
et al., 2008). This takes place via electron transfer during the reduction of NADP+ to 
NADPH. The electron transfer to molecular oxygen (O2) results in the generation of O2.- 
(Bedard and Krause, 2007; Lambeth, 2004). The NOX family of enzymes primarily 
consists of 7 members; NOX 1-5 and DUOX 1/2 (Bedard and Krause, 2007). Figure 4 






Figure 4: Phylogeny tree of the NOX family. 
Adapted from: http://pathology.emory.edu/Lambeth/noxfamilypage.html  
The family now consists of 7 members in human, with orthologs in mouse, rat, Drosophila and C. 
elegans. A family tree constructed by comparing the sequences of the gp91phox-homology domain 
reveals three subfamilies: a gp91phox-like group, a Duox group, and a more distant homolog 
consisting of a single member, Nox5. 
In this family, NADPH Oxidase 2 (NOX2) or previously referred to as phagocytic NOX 
was the first isoform discovered and was studied in immune cells in relationship to host 
defense (Bedard and Krause, 2007; Lambeth, 2004; Lambeth et al., 2007). Due to this 
discovery ROS was initially perceived as detrimental as it was shown to be involved in 
the killing of microbial organisms. This is characterized by an over-generation of ROS 
also known as ‘respiratory burst’, in response to pathogen invasion (Poolman et al., 
2005). The excessive ROS levels are then directly involved in the ‘killing’ process by 
damaging cellular structures and/or indirectly involved via activating release of cytokines 






The diagram in Figure 6 below illustrates that the mechanism of NOX activation can be 
classified into 2 subtypes: the classical NOX enzymes (NOX 1-3) that require the 
assembly of subunits and non-classical NOX enzymes (NOX4-5 and DUOX1/2) that can 
be activated without the assembly of cytosolic subunits. The classical NOX isoform is a 
6- alpha helice transmembrane protein. It is made up of 2 membrane-bound subunits; 
gp91 (catalytic) and gp22 (regulatory) and 3 cytosolic subunits p47, p67 and Rac  
(Kawahara et al., 2007; Lambeth, 2004; Lambeth et al., 2007). The assembly of the 
membrane-bound and cytosolic subunits, constitutes an active NOX enzyme (Figure 5). 
The signal for this assembly typically begins with the phosphorylation of the cytosolic 
p47 subunit, which leads to the translocation of p67 and Rac together with p47 to the 
membrane bound subunits resulting in the assembly of an active NOX enzyme. Previous 
studies have identified Protein kinase C (PKC) as one of the kinases involved in the 
phosphorylation of the p47 subunit and positive regulation of NOX activity (El Benna et 
al., 1996; Faust et al., 1995). 
 
As mentioned earlier, the first NOX enzyme NOX2, was discovered in immune 
phagocytic cells. Increasing evidence from subsequent studies showed that non-immune 
cells also produce ROS. This was linked to the discovery of the other NOX isoforms 
(Kawahara et al., 2007). Furthermore the levels of ROS produced were found to be not 
excessive or physiologically detrimental. This created a paradigm shift where by NOX-
derived ROS also functions as an essential signaling molecules/ secondary messengers 
(Bedard and Krause, 2007; Brown and Griendling, 2009). 
 
Table 1 provides a summary highlighting the cellular distribution, subcellular localization 
and physiological functions of the NOX isoforms. These will also be discussed in the 
upcoming sections. 
 
Having an overview of the biophysical characteristics of the NOX family the next section 






Figure 5: Schematic representation of 
NOX2 enzyme activation. 
Adapted from: 
Berdard  et.al, Physiology Reviews 2007 
 
 
Figure 6: Schematic representation of the various mechanisms of activation. The 
cofactors/subunits required for the activation are highlighted. Diagrammatic 
representation of the transmembrane topology and domains of the NOX isoform 
 
Adapted from: 









(ii) Subcellular localization of NOX enzymes 
The subcellular localization of the different NOX family members varies between cell 
lines. The localization of this enzyme appears to be crucial in determining  
compartmentalized ROS generation and subsequent activation of redox signaling 
pathways, which target redox-sensitive molecules within the space of the sub-cellular 
compartment (Ushio-Fukai, 2006). These are described below.   
 
Caveolae/Lipid rafts) 
Many signaling molecules such as G protein-coupled receptors, death receptors, G-
proteins, receptor tyrosine kinase, Src family kinases and PKC are concentrated on 
caveolae/lipid rafts microdomains (Ushio-Fukai, 2006). The close proximity/ 
compartmentalized localization of these molecules, is essential for efficient activation of 
the downstream signal transduction events. The importance of NOX localization in 
caveolae/lipid rafts has been highlighted in various studies. In vascular smooth muscle 
cells (VSMCs), stimulation with angiotensin II (Ang II) results in the activation of AT1 
receptor (AT1R) and its translocation to the caveolin-1 containing lipid raft domains (Cai 
et al., 2003; Park et al., 2006). The activation of AT1 receptors promotes Rac1 
translocation and subsequent assembly/activation of NOX1 into the lipid rafts leading to 
increased localized ROS production. ROS production leads to activation of redox 
signaling pathways that result in vascular hypertrophy and eventually may lead to 
hypertension (Cai et al., 2003; Touyz and Schiffrin, 2004). Other signaling pathways are 
as follows; 1. Activation of redox-sensitive transcription factors such as AP-1 and NF-κB 
that contribute to inflammation, 2.The regulation of the activity and/or expression of 
matrix metalloproteinases (MMPs) that leads to the remodeling of extracellular matrix 
(ECM) and 3. The activation of ion channels such as Ca2+ ion channels that result in 
cellular migration and contraction (Touyz and Schiffrin, 2004). A multitude of these 
factors eventually lead to the vascular inflammation, remodeling and altered vascular 









The localized ROS production in the nucleus is involved in the regulation of redox-
sensitive transcription factors such as  include SP-1, AP-1, NF-κB, p53 and Nrf2 (Ushio-
Fukai, 2006) . The activation of transcription factors leads to subsequent gene regulation, 
activation of signaling pathways and physiological changes in the cell. In this aspect, 
previous studies have shown that NOX localization in the nucleus to be crucial in cell 
signaling. In VSMCs, NOX4 preferentially localizes to the nucleus (Lassègue and 
Clempus, 2003). The nuclear localization has been studied to be involved in oxidative 
stress response gene expression. Some of the target genes involved are as follows; 1) Cell 
cycle proteins such as Cyclin D and p21 that are involved in regulating cell growth 2) 
Pro-apoptotic proteins such as Bax, Fas and Noxa 3) Cytokines such as Interleukin-6( IL-
6), IL-1 and  TNF-α and 4) Cell adhesion molecules such as VCAM-1 and ICAM-1  
 
Endosomes 
It has been suggested that NOX enzymes are found on internal membrane structures 
(Ushio-Fukai, 2006). Some studies have reported NOX5 has to be localized not only on 
the plasma membrane but also on perinuclear compartments such as the endoplasmic 
reticulum (ER) (Jagnandan et al., 2007). NOX-dependent ROS production in endosomes 
is involved in proinflammatory immune responses (Ushio-Fukai, 2006). A study by Li 
et.al, highlighted that in VSMCs, the binding of Interleukin-1β (IL-β) to the IL -1 
receptors (IL-1R) promoted the endocytosis of the receptors to the endosomes. This was 
crucial for the simultaneous translocation of the plasma membrane-bound NOX2. NOX2-
derived ROS contributed to the subsequent activation of NF-κB. 
 
Cell-matrix adhesions and cell-cell contact 
Cell- matrix adhesions serve as focal points or junctions for the recruitment of signaling 
proteins/molecules involved in redox-sensitive signaling pathways that promote cell 
function (Ushio-Fukai, 2006). These junctions serve as centers for ‘cross-talk’ between 
structural proteins such as the integrins and regulatory signaling molecules such as 
tyrosine kinases and small G-proteins. The ROS-generated by NOX present in this 





the interaction of these complexes at the cell-matrix junctions (Ushio-Fukai, 2006). The 
synergistic effect of ROS production and the activation of signaling complexes at focal 
adhesions, promotes downstream signaling pathways that lead to cell 
survival/proliferation and gene expression. 
 
The loss of cell-cell contact in endothelial cells is an important mechanism that initiates 
cell migration and proliferation involved in angiogenesis and metastasis. The primary 
molecule responsible for cell-adhesion is vascular endothelial (VE)-cadherin. Tyrosine 
phosphorylation of the VE-cadherin complex is required for the disruption of the cell-cell 
junction mediated via c-Src which is ROS dependent. Studies have not yet clearly 
demonstrated the link between NOX-derived ROS at the cell-cell junctions and 
migration/angiogenesis. However it has been shown that vascular endothelial growth 
factor (VEGF) promotes Src-mediated phosphorylation of VE-cadherin, leading to loss of 
cell-cell contact thus promoting angiogenesis (Ushio-Fukai and Alexander, 2004; Ushio-
Fukai and Nakamura, 2008).  
 
Lamellipodial leading edge and focal complexes 
NOX-derived ROS serve as signaling molecules during cytoskeletal reorganization and 
directed cell migration (Ushio-Fukai, 2006). Transitory migratory cells create integrin-
like structures with tyrosine-phosphorylated proteins termed focal complexes. 
RhoGTPases Rac1 and Cdc42 are involved in focal complex formation within 
lamellipodia and filopodia, respectively, whereas RhoA facilitates the maturation of focal 
complexes into stable focal adhesions. In endothelial cells (ECs), NOX2 and Rac-1 have 
been shown to be involved in cell migration. Furthermore the PI3K-Rac pathway 
activation was shown to be involved in ROS production required for cytoskeletal 
reorganization and directed cell migration. TNF-α stimulation results in the translocation 
of the NOX cytosolic subunits to the plasma membrane leading to NOX enxyme 








(iii)Physiological and Pathological functions of NOX enzymes  
Cell survival/ proliferation and cellular senescence 
ROS serve as mitogenic factors that encourage survival and growth (D'Autréaux and 
Toledano, 2007; Pervaiz and Clement, 2007). In addition they function as secondary 
signaling molecules that are essential in promoting cell survival signaling pathways 
(Brown and Griendling, 2009). In the context of cancer, it is now being well established 
that most tumor cells have higher ROS levels in comparison to their normal counterparts 
(Pervaiz and Clement, 2007). Cancer therapy is now exploring redox- modulating 
strategies that are able to alter cellular ROS levels and the antioxidant systems (Wondrak, 
2009). In human colon tumor cells (HCT116 and HT29), NOX1-derived ROS has been 
shown to be crucial in promoting cell survival/ proliferation and angiogensis (Ushio-
Fukai and Nakamura, 2008). The ROS produced mediates the activation of Ras and Erk 
1/2 kinase that leads to the phosphorylation of Ets-1 transcription factor that  leads to the 
increased expression of Cyclin D. Cyclin D activity promotes progression into the S 
phase of the cell cycle and thus promotes cell growth and proliferation (Brown and 
Griendling, 2009). In addition to ROS produced by NOX1, H2O2 produced via O2.-  
generated by NOX4 has also been shown to promote cell survival and growth in response 
to factors such as angiotensin and transforming growth factor-β (TGF-β). NOX4 derived 
ROS induces the phosphorylation of Retinoblastoma protein (Rb) and eukaryotic 
translation initiation factor 4E (eIF4E) (Brown and Griendling, 2009). Rb is a tumor 
suppressor that suppresses the cell cycle progression and is deactivated by 
hyperphosphorylation. In contrast, the activity of eIF4E is enhanced by phosphorylation. 
This eventually leads to cell growth and survival. In addition to promoting cell 
proliferation/survival, ROS is also able to cause cell cycle arrest leading to cellular 
senescence (Finkel et al., 2007; Finkel et al., 2006). There is increasing evidence/studies 
establishing the relationship between ROS and senescence (Finkel et al., 2007; Finkel et 
al., 2006; Schilder et al., 2009). These studies are important in gaining knowledge on the 









There are various forms of cell death being classified in current literature (Kroemer et al., 
2009). The type of cell death is dependent on the triggers involved in the signal 
transduction of cell death. The principle forms of cell death are apoptosis, necrosis and 
autophagic cell death. Apoptosis is referred to as a form of programmed cell death. The 
‘hallmarks’ or morphological characteristics associated with apoptosis are plasma 
membrane blebbing, cell rounding, retraction of pseudopodes, chromatin condensation, 
DNA fragmentation and reduction of cellular and nuclear volume. In the biochemical 
aspect of apoptosis, there are 2 major types of apoptotic signaling pathways.  They are 
namely mitochondrial/intrinsic pathway and extrinsic death receptor-mediated pathway. 
Cross-talking between these 2 signaling pathways have been highlighted in previous 
studies. In contrast, necrosis is characterized by rupture of the plasma membrane leading 
to loss of cellular contents, swelling of the cytoplasm and cytoplasmic organelles and 
moderate chromatin condensation. Autophagic form of cell death is defined by a lack of 
chromatin condensation, massive vacuolization and formation accumulation of 
autophagic vacuoles. Current studies have shown that ROS plays a crucial role in the 
signal transduction of all these various forms of cell deaths. NOX-derived ROS has been 
studied to result in cell death in different types of cell lines (Ahmad et al., 2004a; Brar et 
al., 2003; Chou et al., 2004). Tumor necrosis factor-α (TNF-α) via interaction with 
Tumor necrosis factor receptor 1 (TNFR1) has been well-studied to promote receptor-
mediated cell death. NOX1 and Rac have been shown to be recruited to the death 
receptor complex comprised of TNF receptor associated death domain (TRADD) and 
Receptor interacting protein 1(RIP1) (Brown and Griendling, 2009). The ROS derived 
from the activation of NOX1 results in the prolonged activation of JNK kinase leading to 
necrosis. NOX2 derived ROS in particular H2O2, promotes the binding of TNF receptor 
associated factor 2 (TRAF2) to TNFR/TRADD complex. This results in the activation of 
IKK and the subsequent activation of NF-κB leading to necrosis.  
Cancer 
Tumor initiation and progression is tightly linked to cell survival/proliferation and cell 
death (Brar et al., 2003; Kamata, 2009; Pervaiz and Clement, 2007). The involvement of 





The upregulation/enhancement of cell survival/proliferation pathways and/or the 
dysregulation/ suppression of cell death signaling pathways contribute to tumorigenesis. 
ROS is viewed as an initial factor involved in cellular transformation and tumor 
development. The link between the regulation of NOX enzyme activity/expression and 
the development of cancer has not been concretely established. However, currently there 
is progress in studies showing the involvement of NOX-derived ROS in the progression 
of tumor development (Chua et al., 2009; Juhasz et al., 2009; Kamata, 2009). NOX1 has 
been well-studied and has been shown to be involved in the activation of Ras oncogene 
(Kamata, 2009). The activation of Ras is crucial in controlling the transcription of NOX1. 
In the progression of esophageal adenocarcinoma (EA), NOX5-S isoform derived ROS 
has been shown to activate downstream survival signaling pathways (Hong et al., 2010; 
Si et al., 2008; Si et al., 2007). The involvement of NOX5-S in EA will be discussed in a 
later section. 
 
Besides the regulation of cell death and/or cell survival signaling pathways, angiogenesis 
and metastasis/migration are factors involved in cancer progression. NOX-derived ROS 
has also been widely studied to be involved in cellular migration and angiogenesis 
(Ushio-Fukai and Nakamura, 2008). H2O2 production mediated by NOX2 in response to 
factors such as vascular endothelial growth factor (VEGF) and angiopoietin is known to 
activate kinases like Akt and c-Src (tyrosine kinase) (Brown and Griendling, 2009). The 
activation of kinases then leads to the regulation and expression of genes involved in 
angiogenesis. MMPs (Metallomatrix proteinases) are a group of proteins involved in 
regulating cellular migration and metastasis. NOX4-derived ROS is involved in the 
activation of MMPs that lead to regulation of genes involved in metastasis (Brown and 
Griendling, 2009). 
 
A study by Juhasz et.al, investigated the expression levels of the different NOX isoforms 
in various cancer lines via quantitative real time RT-PCR. They also extended their study 
to non-tumor and tumor tissues in order to analyze the tumor-specific expression of the 
NOX isoforms (Juhasz et al., 2009). This data is represented in Table 2 adapted from the 





research on evaluating the role of NOX isoforms in tumor development and developing 
cancer therapeutic strategies modulating NOX expression and activity. Thus it is evident 
that cellular signal transduction mediated by NOX-derived ROS is crucial in the 
development of cancer. 
Inflammation, immune system 
As stated in the earlier section, the central role of NOX, particularly NOX2 (Phagocytic 
NOX) was traditionally known to be involved in innate immunity. The ROS produced 
plays a major part in host defense in the event of an infection due to the entry of 
microorganism (Bedard and Krause, 2007). Another major role of NOX enzymes would 
be in regulating the levels of pro-inflammatory and anti-inflammatory cytokines 
(Kawahara et al., 2007). ROS generated via NOX serve as secondary signaling 
molecules involved in signal transduction pathways that lead to the production of 
cytokines. A study by Park et.al, showed the direct interaction between NOX4 and TLR4 
(Toll-like receptor 4). TLRs have been characterized to be involved in innate immunity 
and inflammatory responses (Park et al., 2004). The interaction was suggested to be 
essential in LPS (Lipopolysaccharide) - induced production of ROS and sequential 
activation of NF-κB (Park et al., 2004). 
Vascular disease and hypertension 
In the context of vascular biology, ROS species generated by the vascular wall have been 
shown to be detrimental (Cai et al., 2003). ROS can be generated via injury to the 
vascular endothelial wall (endothelial dysfunction), cytokine production and altered 
activity of ROS- generating enzymes such as NADPH oxidases in the cells. The ROS 
produced by the vascular tissue has been shown to act as secondary signaling molecules 
that activate signaling pathways and altered gene expression. The change in gene 
expression results in physiological changes such as vascular remodeling, vascular 
inflammation and altered vascular tone (redox balance) (Cai et al., 2003; Lassègue and 
Clempus, 2003; Touyz and Schiffrin, 2004). 
 
In addition to the diseases discussed in the section above, NOX is also involved in the 
development of sepsis, diabetes, diabetic nephropathy, Alzhimer’s disease and other age-















 Well characterized 
major cellular 
physiological function 
NOX1 High expression: Colon tumor cell 
lines  (HCT116, HT29) and Vascular 
smooth muscle cells 
Intermediate to low expression: 
Uterus, Placenta, Osteoclasts and 
Endothelial cells 
Plasma membrane -ROS derived from NOX1 
has been characterized 




NOX2 High expression: Immune cells: 
Phagocytes, Neutrophils and 
lymphocytes 
Intermediate to low expression: 
Hepatocytes, Skeletal muscle, 
cardiomyocytes, hematopoietic stem 
cells and endothelial cells 
Plasma membrane 
/ at lamelliopodia 
leading edges and 
focal complexes  
-NOX2 derived ROS 
shown to be involved in  
cytoskeletal 
reorganization and 
directed cell migration 
-ROS produced is 






High expression: Inner ear Precise subcellular 
localization is 
unknown 
-NOX3 has been shown to 
be involved in the 
formation otoconia (part 
of the inner ear) 
NOX4 High expression: 
Kidney tissues, Vascular cells 
Intermediate to low expression: 
Osteoclasts, melanomas, keratinocytes, 
endothelial cells, smooth muscle cells, 





(Vascular smooth muscle 
cells) Involved in 
oxidative stress gene 
response 
-In kidney cells (HEK 
293) NOX4 activated via 
LPS stimulation. NOX4  
was shown to be essential 
in proinflammatory 
cytokine production 
NOX5 High expression: Testis, Ovary, Uterus 
e.g: DU145 
( prostate cancer cell line) 
Intermediate to low expression: 
spleen, lymph nodes, vascular smooth 
muscle cells, bone marrow,pancreas, 






-In DU145 (Prostate 
cancer ) has shown to be 
essential in regulation of  






High expression: Thyroid tissue 
Intermediate to low expression: 





peroxide is essential for 
the synthesis of thyroid 
hormones 
Table 1: A summary highlighting the cellular distribution, subcellular localization 











Table 2: Gene expression level of NOX 1-5, DUOX 1 and DUOX2 relative to  
18s rRNA expression (x10-8) in tumor cell lines or normal cells 
 












Figure 7: Schematic representation of NOX5 
Adapted from: Serrander et.al, Biochimie 2007 
 
 
NADPH Oxidase 5 (NOX5) [Gene ID: 79400] is a novel member of the NOX family. 
Currently there are 5 known spliced variants of NOX5; NOX5 α (~84kda), β (~82kda), γ 
(~86kda), δ(~85kda) and a short form ε or S (~65kda) (BelAiba et al., 2007). NOX5 is 
located on chromosome 15 and comprised at least 18 exons (Fulton, 2009). NOX5 gene 
has been identified in humans and a range of other species. However, interestingly, it is 
absent in rodents (Fulton, 2009). Structurally, NOX5 is distinct from the prototypical 
NOX isoform. NOX5 activity or activation does not require the assembly of cytosolic 
subunits (Jagnandan et al., 2007). Furthermore the N-terminal region comprises of 4 EF-
hands that function as calcium binding domains (Bánfi et al., 2004). Figure 7 illustrates 
the structure of NOX5 which comprises of 6 alpha helices held by heme groups held by 2 
iron (Fe) clusters, 2 cofactors NADPH and FAD at the C-terminus and 4 EF-hands at the 
N-terminus.  NOX5-S is unique from the other spliced variants as it lacks the EF-hands.  
  
Initial studies showed that an increase in calcium (Ca2+) levels beyond physiological 





binding of Ca2+ to the EF-hands, induces a conformational change that leads to 
intermolecular interactions between the N-terminus and C-terminal catalytic domain 
which may then cause enhanced ROS production (Fulton, 2009). Subsequent studies 
proved that the activation mechanism is more complex than a mere increase in Ca2+ 
concentration (Serrander et al., 2007). Studies showed that NOX5 can be phosphorylated 
via PKC. PMA (Phorbol ester) is able to induce the phosphorylation of NOX5 via PKC 
(Serrander et al., 2007). Furthermore the study showed that the interplay of both factors; 
optimal Ca2+ concentration and phosphorylation are required for the full activation of 
NOX5. It was shown that phosphorylation sensitizes NOX5 activity; maximal NOX5 
activity at a lower Ca2+ concentration which is more physiologically relevant nanomolar 
concentrations. A study by Fulton et.al reported that calmodulin (CaM), a calcium 
binding protein also regulates the activity of NOX5. CaM binding domains were found 
on the C-terminus rather than the EF domains which are known to function as Ca2+ 
binding domains in NOX5. It was shown that the presence of CaM together with 
elevation in Ca2+ levels, leads to synergistic activation of NOX5 (Tirone and Cox, 2007). 
The presence of CaM binding domains sensitizes and lowers the activation threshold of 
NOX5. A slight elevation in cytosolic Ca2+ levels, was able to result in maximal NOX5 
activity. This added another dimension to the mechanism(s) of NOX5 activation. 
 
To complement the studies on the activation mechanisms, the 2 widely used NOX 
inhibitors; Diphenyiodonium (DPI) and 4'-hydroxy-3'methoxyacetophenone (Apocynin) 
have been used to assess their function on this novel isoform. DPI at submicromolar 
concentrations was shown to be able to inhibit NOX5 activity while apocynin did not 
yield similar results (Serrander et al., 2007). This can be explained as apocynin’s mode 
of mechanism involves inhibiting the assembly of the cytosolic and membrane subunits. 
DPI however, inhibits ROS production via targeting the membrane- bound subunits. Thus 
DPI is more commonly used as a NOX inhibitor. Recently a study by Krause et.al 
identified a novel compound, Melittin from bee venom as a potential NOX5 inhibitor. It 
was suggested that Melittin interacts with the NOX-EF hands on the N-terminus and 






Having explored the biophysical (structural) aspects and the biochemical aspects 
(activation mechanisms), studies progressed with the aim of establishing the 
physiological significance of NOX 5 in humans. However this still remains elusive. ROS 
has been shown to be an important factor in the progression and maintenance of prostate 
cancer. In this context, in the human DU145 (p53 mutant) prostate tumor cells NOX1 and 
NOX5 were identified as the 2 NOX family members present (Brar et al., 2003). NOX5 
was shown to be essential in ROS-mediated cellular proliferation and survival. The 
silencing of NOX5 was shown to decrease basal ROS levels and suppress 
proliferation/cell survival. The treatment of DU145 with NOX inhibitors and antioxidant 
enzymes also reduced ROS levels and suppressed cell survival/proliferation (Brar et al., 
2003). In contrast, silencing of the NOX1 components did not affect cell 
proliferation/survival (Brar et al., 2003). In Human aortic smooth muscle cells 
(HASMCs), NOX5 –derived ROS has been shown to be important in Platelet-derived 
growth factor (PDGF)-mediated cell proliferation (Jay et al., 2008).  A study by R.S 
BelAiba et.al has shown that the NOX5 splice variants are expressed and active in human 
endothelial cells.  The variants were found to be localized on the endoplasmic reticulum 
(BelAiba et al., 2007). The data suggested that the ROS produced via NOX5 promotes 
proliferation and angiogenesis.  
 
The NOX5-S (Short isoform) has been shown to be involved in the carcinogenesis of 
esophageal cells resulting in esophageal adenocarcinoma (EA). Acid reflux damage is a 
major factor contributing to the transformation of EA. NOX5-S was found to be the 
major NOX5 isoform present in SEG-1 EA cells (Fulton, 2009). Lambeth et.al have 
suggested several mechanisms involving NOX5-S expression and the progression of EA. 
NOX5-S is involved in acid-mediated ROS production of in particular, H2O2. The 
expression of NOX5-S was shown to be mediated via elevation of cytosolic Ca2+ levels 
and activation of cAMP response element binding protein (CREB) (Fu et al., 2006). They 
have also reported in another study that COX-2 (Cyclooxygenase-2) is upstream of the 
acid-mediated NOX5-S expression (Si et al., 2007). The redox-sensitive transcription 
factor NF-κB was identified as the downstream factor following the induction of NOX5-





cell proliferation/ survival and suppress apoptosis/cell death. Platelet –activating factor 
(PAF), a pro-inflammatory, mediator was shown to regulate acid-induced NOX-5S 
expression (Si et al., 2008). NOX5-S increases upon PAF treatment and STAT5 was 
identified as the transcription factor causing the increase in NOX5 expression.  Erk1/2 
MAP kinases and cPLA2 (cytosolic phospholipase) were shown to be upstream signaling 
molecules involved in the activation STAT5 that leads to the increased NOX5-S 
expression (Si et al., 2008). NOX5-S differs from the other spliced variants in its mode of 
activity as it does not require the binding of Ca2+ ions.  
 
In Hairy cells (B-cell lymphomas), NOX5 plays an important role in the constitutive 
activation of phosphorylation signals (Kamiguti et al., 2005). The ROS generated 
inhibited tyrosine phosphatases such as SHP-1. In K562 leukemia cells, c-Abl was shown 
to interact with NOX5 in response to H2O2 treatment (El Jamali et al., 2008). H2O2 
treatment was shown to elicit a calcium flux that promoted the activity of NOX5. The 
active c-Abl was also shown to translocate and interact with NOX5 at the membrane (El 
Jamali et al., 2008). The physiological relevance of the c-Abl-NOX5 interaction is not 
known. A recent study by Lambeth et.al, investigated the differential responses mediated 
via Angiotensin II (AngII) and Endothelin-1 (ET-1) in vascular endothelial cells 
(Montezano et al., 2010). Both compounds were shown to upregulate NOX5 expression 
at the transcriptional and translational level. The regulation of NOX5 was shown to be 
calcium and calmodulin-dependent processes. The phosphorylation of Erk 1/2 was linked 
to the increase in NOX5 expression and involved in cell growth and inflammation 
(Montezano et al., 2010). 
 
The functional relevance and significance of NOX5 remains yet to be elucidated. 
However current studies have shown that NOX5 is a growth signaling oxidase/ enzyme 
(Brar et al., 2003). There is growing evidence that NOX5 is an enzyme involved in 
normal growth, survival/ proliferation in neoplastic/ tumor cells (Fulton, 2009; Kamata, 
2009). NOX5 is being currently suggested as a biomarker in prostate cancer. It is one of 
the genes being screened using the commercial Oligo GEarray® system. NOX5 is of 





comparison to the other isoforms. Furthermore NOX5’s presence in the humans but not 
rodents sparks the question of its physiological relevance and role in human cellular 
function.  
Many therapeutic drugs can be classified according to their ability to directly or indirectly 
modulate the ROS levels. The direct targets on regulating ROS levels would be via 
altering the level/activity of the antioxidant defense mechanisms, inhibition of ROS-
producing enzymes such as NOX, augmenting/ suppressing ROS-related signal 
transduction pathways. Resveratrol (RSV), a well-studied natural compound found in 
plants is an example of a chemotherapeutic compound that is able to modulate 
intracellular ROS levels. In addition, RSV is currently commercially available as a health 
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-ROS regulation   






1.4 Resveratrol (RSV) 
 
Figure 9: Chemical structure of Resveratrol  
 
(i) Chemical structure and biological properties 
 
Resveratrol (3, 5, 4’-trihydroxystilbene) is a naturally occurring polyphenolic phytoalexin 
in plants such as grapes and berries (Pervaiz and Holme, 2009). Figure 9 illustrates its 
chemical structure. It is a constituent in red wine and is produced by plants as a form of 
host defense in the event of a fungal or bacterial attack. RSV is presently being studied 
for its cardiovascular protective effects, anti-inflammatory effects, anti-aging properties 
and it potential as a chemotherapeutic/ chemopreventive agent.  
 
Being a lipophilic phenol, it crosses the plasma membrane readily and is well absorbed 
and metabolized when administered orally (Holme and Pervaiz, 2007). Recent studies 
have shown that, RSV is able to exert several physiological effects such as cell 
survival/proliferation, cell death and senescence (Holme and Pervaiz, 2007; Pervaiz, 
2004; Pervaiz and Holme, 2009). These diverse conditions are dependent on the cell type 
and concentration. At low concentrations, RSV promotes cell survival and proliferation. 
Contrastingly at higher concentrations, RSV exerts cell cycle arrest, suppresses survival 
signaling and promotes cell death.  In addition to modulating the physiological outcome, 
RSV also alters the cellular redox status in a dose-dependent manner. This unique ability 
of RSV, has led to studies portraying its dual characteristic nature as a pro-oxidant and 










(ii) Modulation of cellular function 
 
As discussed earlier, a dose-dependent range of cellular effects can be observed during 
RSV treatment. RSV exerts these effects via targeting cellular signal transduction 
pathways that alter gene expression and the physiological condition of the cell. Several 
studies have well-established the ability of RSV to activate and repress signaling 
pathways. 
 
RSV is able to modulate hormone and growth factor signaling (Pervaiz and Holme, 
2009). RSV has structural similarity to Class I estrogens. In particular, its biological 
activity is comparable and thus able to activate estrogenic signaling pathways. It is able 
to mediate hormone-receptor mediated gene transcription. In addition to mimicking 
estrogen activity, studies have also shown that RSV is able to affect the male hormone, 
androgen. In the context of growth factors, RSV is able to exert an indirect and/or direct 
effect on pathway; A well studied pathway would be insulin signaling. RSV is able to 
have a direct interaction with the insulin receptors or indirectly modulate insulin secretion 
from target cells.  
 
Studies have shown that RSV is able to activate/ modulate signal transduction pathways 
such as the MAP kinase signaling pathways, JAK/STAT signaling pathways, PI3K/Akt 
pathway and cAMP/cGMP signaling pathway (Holme and Pervaiz, 2007; Pervaiz and 
Holme, 2009). Regulation of these signaling pathways is related to modification of gene 
expression and various physiological effects on the cell. The ERK1/2 MAP kinase 
signaling pathway is well studied and has been shown to be involved in cell 
survival/proliferation and differentiation. However the p38 and SAPK are involved in 
stress-related, inflammation and cell death signal transduction pathways. The PI3K/Akt 
regulates the pro-survival signaling pathway. The phosphorylated active Akt, targets 
many downstream signaling molecules such as transcription factors, pro-survival and 






The activation of gene transcription and modulation of gene expression are downstream 
effects of the activation of signal transduction pathways (Pervaiz, 2004; Pervaiz and 
Holme, 2009). Some of the targets include Egr (Early growth response) gene, immediate-
early genes such as p53, c-fos, c-jun, and pRb. The activation of Egr gene promotes cell 
proliferation and survival. Contrastingly, activation of c-fos and c-jun factors, suppress 
the cell survival pathways and promote cell death pathways.  
 
RSV regulates receptor mediated cell death. Some of the well-characterized pathways are 
RSV induced TNF-α mediated cell death and TLRs (Toll-like receptors). In addition RSV 
is also involved in CD95 mediated cell death via upregulation of the CD95 receptor 
expression. Mitochondrial –mediated intrinsic apoptotic pathway is also regulated via 
RSV treatment.  
 
(iv) RSV modulation of cellular redox status 
 
RSV is currently being well-established as a pro-oxidant and anti-oxidant. At low 
concentrations, RSV generates a mild pro-oxidant oxidant that promotes cell survival/ 
proliferation (Ahmad et al., 2004a). The shift in the redox status prevents the generation 
of H2O2 and the subsequent activation of cell death signaling pathways (Ahmad et al., 
2004a). At high concentrations of RSV, H2O2 is the predominating ROS species. H2O2 
then serves as a secondary signaling molecule that leads to the activation of cell-death 
signaling pathway. A well-studied example would be RSV-induced ROS production that 
mediates the intrinsic/mitochondrial cell death (Ahmad et al., 2004b). 
  
ROS produced by RSV is also involved in DNA damage. RSV in response to DNA 
damage is able to bind to DNA, create genotoxic, metabolic stress and produce 
inflammatory ROS.  In the event of DNA damage there will be disruption of the 
coordinated progression of cell cycle through the various phases G1, S and G2. This 
would lead to cell cycle arrest and eventually cell death. Two well-known targets of RSV 
that regulate cell cycle are p53 and Retinoblastoma (Rb). Both proteins have been well 
studied as tumor suppressors. At a high concentration of 100uM RSV, Rb is 





been studied that RSV increases the expression level and activity of p21 (cyclin 
dependent kinase inhibitor) thus resulting in S/G1 transition phase arrest leading to 
inhibition of proliferation. 
 
(v) Autophagy and Metabolism 
 
Autophagy is termed as a form of programmed cellular degradation during which the 
intracellular components are taken up by the lysosomal machinery (Kroemer et al., 
2009). This event is usually activated in response to triggers such as, nutrient deprivation, 
microbial infection, programmed cell death and other cellular stresses (Kroemer et al., 
2009). RSV interacts with beclin-1, a central player in the autophagic process. Beclin-1 
has been shown to interact with Bcl2 and other proteins involved in autopaghy. RSV also 
regulates autophagy via redox sensitive mechanisms. ROS production via RSV regu                               
lates the expression of proteins such as of AMPK, Akt and mTOR (Pervaiz and Holme, 
2009). The regulation of these proteins can result in mitochondrial biogenesis in a 
nutrient rich environment or growth arrest in a nutrient-deprived one (Pervaiz and 
Holme, 2009). Thus, RSV has been well characterized to be involved in glucose uptake 
and cellular metabolism via alteration of cellular redox status. It has a dual role in cellular 
metabolism. RSV regulates metabolism by acting on Sirtuins (SIRTS), a class of NAD+ 
dependent histone deacetylases. The interaction between RSV and SIRTS has been 
shown to be involved in the inhibition of cell growth and activation of programmed cell 
death (Pervaiz and Holme, 2009). In the context of cancer, it has been studied that RSV 
activates SIRT1.This activation of SIRT1 leads to its interaction and subsequent 
activation of the FOXO group of transcription factors (Pervaiz and Holme, 2009). This 
regulates the p53 gene expression levels and results in growth arrest and activation of 
gluconeogenic signaling pathways (Pervaiz and Holme, 2009). 
 
(vi) Resveratrol (RSV) and Reactive oxygen species (ROS)/NADPH Oxidase (NOX)  
 
RSV modulates cellular redox status  in a dose-dependent/concentration manner. This has 





expression leading to the modulation of cellular signaling pathways. The modulation of 
signaling pathways eventually results in the alteration of the cell’s physiological status. 
The link between RSV and NOX has been extensively studied in the immune and 
vascular system (Park et al., 2009; Poolman et al., 2005; Spanier et al., 2009; Tang et 
al., 2007). A study by Carluccio et.al., showed that RSV is able to counter the action of 
homocysteine in vascular cells. RSV is able to reduce ROS levels and thus inhibit NF-κB 
and NOX activation mediated via VCAM-1 induction in the presence of elevated 
homocysteine levels (Carluccio et al., 2007). Thus RSV has been studied to elicit 
cardioprotective effects. In human leukemia cells Ahmad et.al, have shown that RSV of 
low doses (4μM -8μM) are able to inhibit the activation of NADPH Oxidase complex. 
RSV was shown to increase intracellular levels of ROS and inhibit drug-induced 
apoptosis. Thus inhibition of NOX activity was shown to reverse the effect of RSV and 
promote cell death.  
 
In promyelotic leukemia cell lines such as U937 and HL-60, RSV has been shown to 
block proinflammatory effects and subsequent tumor initiation and progression. A study 
by Holmes-McNary et.al., showed that RSV is an efficient inhibitor of NF-κB activity 
and blocks NF-κB-mediated gene expression. NF-κB is a major regulator of TNF-
mediated proinflammatory signaling pathways. Furthermore the study showed that RSV 
is able to induce apoptosis in mouse embryonic fibroblasts following H-Ras mediated 
transformation (Holmes-McNary and Baldwin, 2000). Thus RSV was shown to elicit 
anti-tumor effects. RSV has also been studied to affect cell cycle progression in U937 
cells. The landmark study be Park et.al showed that relatively low concentrations of RSV 
(30μM-60μM) is able to create a S/G2 phase cell cycle arrest. It is reversible process as 
the withdrawal of RSV from the medium led to the progression in the cell cycle (Park et 
al., 2001). This study boosted the possibility of RSV as a cancer therapeutic drug in 
leukemia cells.  
 
In a nutshell, RSV is a multi-faceted drug that is able to function as a pro oxidant or anti 
oxidant, regulate NOX activity and/or expression in different ways in dose-dependent and 







progression. These contrasting effects have been shown in many different systems, as 
highlighted in the sections above. 
 
1.5 Aim of the study 
NOX5 has been identified as a novel member of the ROS-generating family of enzymes, 
NOX.  RSV has been well-studied to possess both pro-oxidant and antioxidant properties. 
Furthermore, it has been established that RSV is able to exert dose-dependent 
physiological cellular effects such as, cell proliferation, apoptosis and senescence/ cell 
cycle arrest. Currently, there is increasing evidence suggesting RSV’s ability to regulate 
NOX activity and expression. NOX5 is known to be expressed in lymphoid tissue and 
spleen but absent/low expression has been shown in circulating lymphocytes (Kamiguti et 
al., 2005). Current literature identifies NOX5-L as the predominant isoform that is  
present and plays a functional role in lymphoma cell lines. As mentioned previously RSV 
is able to modulate NOX expression and activity in leukemia cells.  The main aim of the 
study was to investigate RSV’s effect on the novel isoform NOX5’s, expression level in 
U937 (monocytic lymphoma) cells and to assess if this was related to the cellular redox 
status. 
 
1.6: Mode of action of the classes of compounds used in the study 
ROS scavengers and NOX inhibitor DPI 
Tiron abrogates the production of O2.- ions. Inhibiting the production of O2.- ions would 
deter the progressive formation of other ROS species. Catalase converts the H2O2 
produced to H2O and O2.- . NAC functions via altering the GSH-GSSG ratio. DPI acts via 
inhibiting NOX activity and thus prevents the generation of O2.- ions. 
 
ROS producers 
DDC acts via inhibiting the action of SODs (Superoxide dismutases). Thus the O2.-  ions 
generated do not get converted to H2O2. SIN-1 chloride and DETA-NO are compounds 
that produce nitric oxide. 
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2.1.1: Cell Line 
 
U937 (Monocytic lymphoma) cells were purchased from American Type Culture 
Collection (ATCC) (Rockville, MD, USA) and cultured in Roswell Park Memorial 
Institute (RPMI)-1640 medium (Invitrogen) and supplemented with 10% heat-inactivated 
fetal bovine serum (FBS) (Gibco),1mM sodium pyruvate (Hyclone), and 4500mg/L D-
glucose (Hyclone) as recommended by ATCC. The cell line was maintained in a 37°C, 
5% CO2 Incubator (Sanyo). 
 
2.1.2: Chemicals 
Diethyldithiocarbamate (DDC), Resveratrol (RSV), Phorbol 12-myristate 13-acetate 
(PMA), Tiron, Catalase, N-Acetyl-Cysteine (NAC), Diphenylene iodonium (DPI), (3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT), Phosphatase 
inhibitors, Tris Base and Glycine were purchased from Sigma-Aldrich. Hydrogen 
peroxide (H2O2) was purchased from Calbiochem. Complete protease inhibitors (with 
EDTA) were purchased from Roche. Methanol was supplied by Merck. Sodium Dodecyl 
Sulphate (SDS) was purchased from Sinopharm chemicals. Dichloroflurorescein 
diacetate (H2DCFDA-AM) and Propidium iodide (PI) were purchased from Molecular 
Probes (Invitrogen). Ponceau S was purchased from Sigma. 30% Bis-acrylamide was 
purchased from Biorad. Dithiothreitol (DTT) was bought from Roche and Ammonium 
persulfate (APS) was purchased from USB chemicals. DTT and APS was made up as a 
1M and 10% stock solutions respectively and stored at -20˚C. Fresh stocks were made up 
once every 3 months. 
 
2.1.3: Antibodies  
Anti-NADPH oxidase 5 (Nox5) (H-160) antibody (anti-rabbit) was purchased from Santa 
Cruz Biotechnology.Inc. Anti-β-actin (anti-mouse) monoclonal antibody used as a 
loading control was purchased from Sigma-Aldrich. Anti-phospho CREB (anti-rabbit) 
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was purchased from Cell signaling. Anti- total CREB (anti-goat), anti-MnSOD (anti-
rabbit) and anti-Cu/ZnSOD (anti-mouse) were supplied by Santa cruz Biotechnology. 
Anti-catalase (mouse) monoclonal antibody was purchased from Sigma-Aldrich. Rabbit 
anti-goat HRP, goat anti-mouse HRP and goat anti-rabbit HRP were purchased from 
Pierce, Thermofisher Scientific and Biorad. 
 
2.1.4: Equipment 
The standard equipment for SDS-PAGE (Polyacrylamide gel electrophoresis) and Wet 
transfer were purchased from Bio-Rad. Nitrocellulose membrane (0.22μm pore size) was 
purchased from Bio-Rad. All absorbance readings for Bradford assay and MTT assay 
were done using the PolarStar Optima Microplate reader (BMG Labtech, GmBH, 
Germany) 
 
2.1.5: Detection of Chemiluminescence (Western Blotting) 
The HRP-Conjugated substrate; West Pico Luminol and West Pico Enhancer and X-ray 
films were purchased from Pierce Thermofisher scientific. 
 
2.2: METHODS/PROTOCOLS AND PLAN OF INVESTIGATION 
 
2.2.1: Maintenance and seeding of U937 cells for experiment 
The suspension culture of U937 was grown in RPMI-1640 as recommended by ATCC. 
The cells were subcultured every 2-3 days in T75 cm2 flasks (NUNC) at an approximate 
seeding density of (0.02-0.05) x 106cells/ml. For experiments, the cells from flasks with 
85%-95% confluency were first collected in a 50 ml falcon tube (Greiner) and 
centrifuged at 1200 rpm for 5min. Following that, the supernatant/ spent media was 
aspirated and resuspended in 1x phosphate buffered saline (PBS) without Mg2+ and Ca2+ 
(Hyclone). From the cell suspension a 100 μl aliquot was obtained to perform cell 
counting. Trypan blue exclusion assay was used for cell counting. A dead cell percentage 
of ≤ 10% was considered as a good cut off. The remaining cell suspension in the falcon 
tube was centrifuged at 1200 rpm for 5 min. Meanwhile the number of cells was counted 
using a hemocytometer prior to seeding onto 60 mm dishes for experiment. After 
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centrifuging, the supernatant was aspirated and resuspended with fresh medium to a 
concentration of 1x106cells/ml. From this stock of cell suspension the cells were seeded 
into 60 mm (Corning) dishes at a final cell density of 0.5x106cells/ml in total volume of 4 
ml. 
 
2.2.2: Preparation of Resveratrol (RSV), DDC, H2O2, Tiron, NAC, Catalase, DPI,  
SIN-1 Chloride and DETA-NO 
 
After plating, the cells were left in the incubator to recover for 2-3 hr. RSV was 
constituted in DMSO (Dimethyl sulfoxide) to a stock concentration of 1 M. The 
concentration of DMSO was 0.0025 %. The stock was then further diluted in 1x PBS to 
the desired working concentration(s). DDC was weighed out and constituted in 1x fresh 
PBS each time to a stock concentration of 200 mM. The stock was further diluted to the 
desired working concentrations of 25 μM, 50 μM and 100 μM. H2O2 was an initial stock 
of 8.8 M. It was reconstituted in PBS to a stock solution of 1 M. Prior to making up the 1 
M stock, the absorbance reading was taken to calculate the effective concentration of 
H2O2. This is because H2O2 solutions are unstable and can undergo decomposition. Thus 
for absolute quantification the absorbance was measured at 240 nm. The calculations 
were then based on the molar extinction coefficient of 43.6 M-1cm-1. A standard 3% 
solution is 0.88 M, and at a 1:100 dilution would have an A240 of 0.388. The 1 M stock 
was then further diluted to the working concentrations of 50 μM, 100 μM and 200 μM. 
Tiron was weighed out and made up in PBS to a stock concentration of 100mM. The 
stock solution was then further diluted to a working concentration of 3mM. Catalase 
(Liquid) was diluted to a stock concentration of 10000units/ml and further diluted to a 
working concentration of 1000 units/ml. NAC was weighed out and constituted in PBS to 
a concentration of 80 mM. DPI was a stock concentration of 100 mM and diluted to the 
working concentration of 2.5 μM. SIN-1 chloride and DETA-NO chloride were weighed 
out and constituted to a stock concentration of 10 mM and further diluted to the working 
concentrations of 250 μM, 500 μM and 1 mM.  
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2.2.3: Western blotting  
A) Sample preparation 
Cell pellet from samples were lysed in cold 1X Radio Immunoprecipation (RIPA) Buffer 
[ 20 mM Tris-HCl (Promega) pH 7.4, 150 mM NaCl (Sigma), 1 mM Na2EDTA(Sigma), 
1 mM EGTA(Sigma), 1% Triton-X (USB chemicals), 1% deoxycholate (Sigma), 2.5 mM 
sodium pyrophosphate (Sigma) and 1 mM β-glycerophosphate (Fluka)]. This was 
prepared according to the Cell signaling recipe. Triton-X in the RIPA buffer serves as a 
detergent to solubilize the cell membrane proteins. Sodium pyrophosphate and β-
glycerophosphate were added to function as phosphatase inhibitors. Deoxycholate is an 
ionic detergent and is used to disrupt protein interactions. EGTA and Na2EDTA are metal 
ion chelators. Complete protease inhibitors with EDTA (Roche) and Phosphatase 
inhibitors (Sigma) were added fresh to the 1x RIPA buffer prior to lysis. This was to 
prevent the degradation of the proteins and preserve their phosphorylated state. Samples 
were kept at -80°C. Prior to western blotting, cell lysates were centrifuged at 14 000 rpm, 
10 minutes at 4°C. The supernatant was collected in a new eppendorf tube and analyzed 
for protein concentration using Bradford assay. Bradford assay reagent used was 
Coomasie blue plus (Thermofisher Scientific) and the protein standards were constituted 
from a stock of 2mg/ml Bovine serum albumin (BSA) (Thermofisher Scientific). A 
microplate reader (BMG Labtech) was used to read the absorbance measurements and 
protein concentrations. The assay was performed according to the manufacturer’s 
protocol. The Bradford assay works on the principle that an absorbance shift from 465nm 
to 595nm takes place when the reagent binds to the protein in an acidic solution. A colour 
change from brown to blue is observed when the anionic complexes of the reagent react 
with the protein. The binding of protein stabilizes the blue form of the coomasie dye and 
allows for reading the amount of protein present by absorbance measurements. 
 
B) SDS-PAGE gel electrophoresis 
25-50 µg of protein were dissolved in a 5x loading dye [0.313 M Tris-HCl pH 6.8, 10% 
SDS (Sinopharm chemical), 50% glycerol (Merck) and 0.05% Bromophenol blue 
(Biorad)] to final 1x dilution. DTT was added fresh to the 1x loading dye to a final 
concentration of 330 mM. The samples were then incubated at 37°C for 10 minutes. 
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Samples were then loaded into a discontinuous SDS- PAGE gel of 4% (stacking)-10% 
(resolving) or 4%-15% percentages. Electrophoresis conditions were as follows; 85V for 
15 min (to allow proteins to run through the stacking component) and 125 V, at 1hr 
15min. The composition of the 1x gel electrophoresis buffer is as follows: 25mM Tris 
Base, 192 mM glycine and 0.1% SDS at pH 8.3. Prestained molecular weight markers 
[Fermentas (Broad range pager ruler plus) and Invitrogen( MagicMark XP western 
marker) were used to facilitate the estimation of the molecular sizes of the protein bands 
detected. 
 
C) Wet transfer 
The resolved/separated proteins were transferred onto a nitrocellulose membrane using a 
wet transfer system. The 1x transfer buffer was constituted as follows: 25 mM Tris Base, 
0.2 M glycine and 20% methanol at pH 8.5. The transfer conditions were as follows; 380 
mA for 1hr 5mins and the setup was packed with ice. The transfer buffer was kept cold at 
-20˚C. 
 
D) Blocking of nitrocellulose membrane 
The nitrocellulose membrane was blocked in 5% non-fat dry milk (Anlene) constituted in 
tris-buffered saline with Tween-20 (TBST). The TBST was formulated as follows: 20 
mM tris base, 137 mM sodium chloride and 0.1% Tween-20 at pH 7.6. The membranes 
were left to incubate for 1-2 hr at room temperature. 
 
E) Incubation of primary antibody 
The blots were washed 3 times at 10 minute intervals with TBST. Following that, the 
blots were incubated overnight at 4°C with primary antibody. All the primary antibodies 
were diluted (1: 1000) in 5% BSA constituted in TBST with the exception of β-actin. The 
dilution was 1:30 000. 
 
F) Incubation with secondary antibody 
The blots were washed 3 times with TBST at 5 minute intervals. Following that the blots 
were incubated at room temperature with horse radish peroxidase (HRP)-conjugated 
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secondary antibody for 1hour. The secondary antibody was diluted 1: 10 000 in 5% milk 
constituted in TBST for all the proteins of interest except β-actin. The anti-mouse 
secondary antibody used for β-actin was at a dilution of 1:60 000. 
 
G) Chemiluminescence detection 
After washing the blots for 3-5 times with TBST at 15 minutes intervals, 
chemiluminescent substrate [Pierce West pico enhancer and West pico peroxide solution 
mixed in a 1: 1 ratio] was added to the membranes and left to incubate for 5 minute. An 
adequate volume of 2 ml to was added per membrane. Following that the protein was 
visualized using X-ray developer (Konica Minolta).  
 
2.2.4: Cell Viability assay  
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) assay was used 
to analyze cell viability. The MTT assay works by assessing the ability of the enzyme 
mitochondrial dehydrogenase in viable cells, to cleave the tetrazolium rings of the yellow 
MTT compound to form purple formazan crystals. The U937 cells were seeded as 
described previously in a 96-well plate and subjected to treatment with the compounds 
used to assess the cell viability. This was also used as a gauge of the cytotoxicity level 
elicited by the compound at the various indicated doses. The MTT was dissolved in PBS 
to a concentration of 5 mg/ml to give a yellow solution. After the treatment with the 
various compounds, the MTT solution was added to the cells at a final concentration of 
0.5mg/ml per well.  The cells were then left to incubate at 37˚C with 5% CO2 for 3 hrs. 
Following the 3hr incubation the cells were centrifuged at a speed of 4000 rpm for 10 
mins. The supernatant/medium was then aspirated. DMSO (volume equal to the total 
volume of cells) was added to the each well to solubilize the purple formazan crystals. 
The crystals were left to solubilize at 37˚C for 15 minutes. The number of viable cells is 
directly proportional to the level of formazan product formed. A microplate reader (BMG 
Labtech) was then used to measure the absorbance readings at 550 nm to quantify the 
amount of formazan crystals formed. The following equation was then used to convert 
the absorbance readings to percentage cell viability:   
 





2.2.5: ROS (Reactive oxygen species) measurement -DCFDA assay 
 The ROS generation was measured using the oxidation sensitive fluorescent dye 
dichlorofluroscein acetate (H2DCFDA-AM). This assay works on the principle that the 
dye which is cell permeable, will diffuse into the cells and react with the cellular 
esterases. The esterases will then cleave DCFDA to form the cell impermeable form. 
Thus the dye will be retained in the cell. The dye will then become oxidized to its 
fluorescent form via reaction with ROS. The amount of ROS can be quantified by the 
level of fluorescence measured. Laser scanning cytometry (LSC) was used to measure the 
level of fluorescence emitted. LSC measures light scatter and absorption with 
fluorescence and uses laser light scatter in a bright-field visualization mode to give 
qualitative and quantitative data (Holme et al., 2007). The major advantage of LSC over 
conventional cytometry, is the ability to work with solid-phase preparations such as 
adherent cell lines, tissue sections, and cytological smears (Holme et al., 2007). 
Furthermore, besides analyzing the integrated fluorescence of each cell (individual 
event), the LSC is able to collect fluorescence data for individual pixels within a cell area 
and express it as fluorescence signal (Holme et al., 2007). The data obtained can be 
displayed as scatter plots, histograms and scan field images together with statistical 
analysis for each sample (Holme et al., 2007). The sample data can be stored reanalyzed 
using a remote workstation for further evaluation. The fluorescent dye was at the 
excitation wavelength of 495nm and emission wavelength of 525 nm on the LSC. The 
cells were seeded onto 96-well plate as described previously. The DCFDA was 
constituted in DMSO to a stock concentration of 5mM and the cells were incubated in a 
final concentration of 2.5 μM for 20 mins. For short time points 30 minutes and 1hr and 
2hr, the cells were pre-loaded with DCFDA and incubated in the 37˚C, 5% CO2 
incubator. They were treated with the compounds for the desired length of time and the 
level fluorescence intensity was analyzed via the LSC. For longer time points and 
treatments involving pre-incubation with ROS scavengers, the cell were first treated and 
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then 30 minutes before the time point end, the cells were loaded with DCFDA and 
incubated in the 37˚C, 5% CO2 incubator. 
 
2.2.6: Cell cycle analysis 
The cell cycle profile of U937 was analyzed using propidium iodide staining. Propidium 
iodide (PI) dye acts as a double-stranded nucleic acid intercalating agent. It binds and 
produces a highly fluorescent product at an excitation wavelength of 488 nm. PI is 
impermeable to the cell membrane but and is thus excluded from viable cells. It can be 
used to thus quantify the amount of dead cells. Since PI can also bind to double-stranded 
RNA it is necessary to add RNase to the PI solution so that the data obtained will be a 
true reflection of the DNA content. The protocol was adapted from Cornell university 
website. The PI solution was made up to a concentration of 5 μg/ml with 200 μg/ml of 
RNase and 0.1% Triton-x. The U937 cells were seeded as described previously onto 96-
well plate and incubated with the PI solution in the 37˚C, 5% CO2 incubator for 20-
30mins before the end-point of the treatment with RSV. The cell cycle profile was then 
analyzed using the LSC. 
 
2.2.8: Densitometry analysis 
Densitometry software tool was used to quantify the western blot data. This was deemed 
to be advantageous so that the change in protein levels could be more accurately 
analyzed. This method would be a better reflection of the protein levels in comparison to 
just observing visually. The software used was Fujifilm mulitgauge 4.0. The western blot 
film was scanned and saved as a file in the tiff format. Following this, the protein bands 
of interest were selected via the tools from the software. The intensities of the bands were 
obtained as Area/ Pixel via the software’s method of analysis.  
 
2.2.7: Statistical test 
Student’s t-test was performed using Microsoft excel. A two-tailed p-value of ≤ 0.05 was 
considered to be statistically significant. 
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3.1: Cell viability assays for drugs (Setting up of dose responses) 
 
A) RSV exerts several cellular physiological effects 
 
From previous studies it is known, that RSV is able to exert various physiological effects in a 
dose-dependent manner. Furthermore these effects of RSV also vary depending on cell type. 
Thus a cell viability assay was important in order to establish the working doses appropriate 
for the in vitro system. Thus U937 cells were seeded on a 96-well plate at a seeding density 
of 0.25x106 cells/ml, and subjected to a 24 hr and 48 hr RSV treatment at the various doses 
indicated in Figure 1a. At the end of the time point, MTT assay was performed as described 
in the material and methods section to measure the percentage cell viability. The MTT assay 
works on the principle of assessing the mitochondria function. In metabolically active/ viable 
cells the yellow dye is converted to purple formazan crystals via reduction catalyzed by 
mitochondrial reductase enzyme. The control cells (UT) at 24hr was taken as 100% cell 
viability for the calculations. From Figure 1a it can be observed that RSV promotes cell 
proliferation at the concentration ranges of 1μM and 6.25μM. At 24hr the percentage cell 
viability was observed to increase significantly within the range of 10% to 30% relative to the 
control/untreated cells at 24hr. However at 48hr no significant increase in the cell viability 
was observed compared to the control cells. There was no cell proliferation observed 
probably due to the saturation of cell density. At the concentration range of between 12.5μM 
and 50μM, RSV seems to exert a cytostatic effect. The percentage cell viability remained 
relatively constant within the range of (120-130) % and (85-90) % at 24hr and 48hr 
respectively. RSV promotes cell death in U937 at the concentration ranges of 100μM and 
200μM. From the data it can be observed that the cell viability decreases within the range of 
(20-40) % and (60-80) % at 24hr and 48hr respectively. The data at 24hr and 48hr were re-
plotted individually to better reflect the changes in the percentage cell viability at the 
respective time points. Figure 1b shows the reanalyzed data. In Figure 1b ii) the control cells 
(UT) at 48hr was calculated as 100% and the percentage cell viabilities at the various doses 












Figure 1a:  Cell viability assay of U937 in response to RSV treatment 
Cells were subjected to 24hr and 48hr treatment of RSV. The percentage of viable cells 
was then assessed via MTT assay. Error bars represent ± S.D. Number of independent 


















Figure 1b: The data from the fig 1a is being represented individually in (i) and (ii) 
The graph in (i) shows the percentage cell viability following 24hr RSV treatment. The 
control cells (UT) at 24hr was calculated as 100% 
The graph in (ii) shows the percentage cell viability following 48hr RSV treatment. The 
control cells (UT) at 48hr was calculated as 100% 

















b) Cell cycle analysis 
 ( i ) 
 
Fig 1b: The data from the fig 1a is being represented individually in (i) and (ii) 
The graph in (i) shows the percentage cell viability following 24hr RSV treatment. The 
control cells (UT) at 24hr was calculated as 100% 
The graph in (ii) shows the percentage cell viability following 48hr RSV treatment. The 









Figure 1c: PI live cell cycle analysis assay of U937 cells following the indicated doses of RSV 
(i) This diagram shows the cell cycle profile following 12hrs of RSV treatment. 
(ii) This diagram shows the cell cycle profile following 24hrs of RSV treatment. 







Figure 1d: Cellular morphology of cells treated for 24 hrs with increasing doses of RSV and 





In order to relate the cell viability assay with the cell cycle profile, a live cell cycle assay was 
performed using the LSC. Propidium iodide (PI) dye acts as a double-stranded nucleic acid 
intercalating agent. It binds and produces a highly fluorescent product at an excitation 
wavelength of 488nm. PI is impermeable to the cell membrane but and is thus excluded from 
viable cells. It can be used to thus quantify the amount of dead cells. Since PI can also bind to 
double-stranded RNA it is necessary to add RNase to the PI solution so that the data obtained 
will be a true reflection of the DNA content. From the Figure 1c it can be observed that at 
12hrs and 24hrs, increasing doses of RSV treatment resulted in a S to G2/M phase arrest. In 
Figure 1c (i) an accumulation in the percentage S-phase cells from 16% to 24% was observed 
following an increasing dose of RSV treatment from (0 to 25) μM. A corresponding decrease 
in the percentage of G2/M cells from 16% to 11% was observed. This was at 12hrs of RSV 
treatment. Similarly at 24hrs of RSV treatment, in Figure 1c (ii) an increase in the S-phase 
cells from 12% to 23% and a corresponding decrease in G2/M phase cells from 18% to 9% 
was observed. The histograms displaying the individual cell cycle profile are under the 
supplementary figure 1. 
 
Figure 1d shows the morphological changes in U937 cells following RSV treatment at the 
indicated doses. From the figure it is evident that high doses of RSV (above 50μM) resulted 
in cell death. This is in comparison to the lower doses of RSV (below 50μM) where no 













Figure 2a :  Cell viability assay of U937 in response tiron treatment  
Cells were subjected to 4hr treatment of tiron. The percentage of viable cells was then 









Figure 2b :  Cell viability assay of U937 in response to catalase treatment  
Cells were subjected to 4hr treatment of catalase. The percentage of viable cells was 
















Figure 2c :  Cell viability assay of U937 in response to NAC treatment  
Cells were subjected to 4hr treatment of NAC. The percentage of viable cells was then 







Figure 2d :  Cell viability assay of U937 in response to DPI treatment  
Cells were subjected to 4hr treatment of DPI. The percentage of viable cells was then 














Figure 2e :  Cell viability assay of U937 in response to DDC treatment  
Cells were subjected to 4hr treatment of DDC. The percentage of viable cells was then 








           
            
            
            
 
 
Figure 2f:  Cell viability assay of U937 in response to  H202 treatment  
Cells were subjected to 4hr treatment of H202. The percentage of viable cells was then 














     
 
Figure 2g :  Cell viability assay of U937 in response to  SIN-1 Chloride treatment  
Cells were subjected to 4hr treatment of SIN-1 Chloride. The percentage of viable cells 
was then assessed via MTT assay. Mean error bars represent mean ± S.D. (n=3)  
Number of independent experiments (n=3) 
 




          
Figure 2h:  Cell viability assay of U937 in response to DETA-NO treatment  
Cells were subjected to 4hr treatment of H202. The percentage of viable cells was then 






It was essential to establish the evidence that the doses of the compounds selected for 
treatment with U937 did not affect the cell viability. This was crucial as it would show that 
the effect of NOX5 expression was a true effect of the compound administered. In addition 
the cell viability would show that the dose chosen, does not elicit cytotoxic effects. Thus 
MTT assay was performed on the 3 main classes of compounds used in this study; ROS 
scavengers (Tiron, Catalase, NAC), NOX inhibitor (DPI) and ROS producers (DDC, H2O2, 
SIN-1 Chloride and DETA-NO). The modes of action for these compounds have already 
been discussed in the introduction section. 
 
ROS scavengers and NOX inhibitor DPI 
Tiron 
The data in Figure 2a shows the MTT assay performed on U937 to assess cell viability 
following a 4 hr treatment. A concentration range of (0-12) mM was used. The percentage 
cell viability was remained relatively constant within the range of (80-100) %. From literature 
review and cell viability data, the dose of tiron chosen was 3 mM (Yang et al., 2007). At 3 
mM the percentage cell viability was approximately 85% with a standard error of 
approximately ± 15% 
Catalase 
The data in Figure 2b shows the MTT assay performed on U937 to assess cell viability 
following a 4 hr treatment. A concentration range of (0-4000) units/ml was used. From 
literature review and the cell viability data, the dose of catalase chosen was 1000 units/ml 
(Yamamoto et al., 2009; Yang and Park, 2007).  At 1000 units/ml the percentage cell 
viability was approximately 98% with a standard error of ± 12%. 
NAC 
The data in Figure 2c shows the MTT assay performed on U937 to assess cell viability 
following a 4 hr treatment. A concentration range of (0-80 mM) was used. From literature 
review and cell viability data, the dose of NAC chosen was 20 mM (Menon et al., 2007; 
Yang et al., 2007). At 20 mM the percentage cell viability was approximately 130% with a 
standard error of ± 2 %. 
DPI 
The data in Figure 2d shows the MTT assay performed on U937 to assess cell viability 
following a 4hr treatment.  A concentration range of (0-10) μM was used. From literature 





Serrander et al., 2007). At 2.5 μM the percentage cell viability was approximately 100 with a 
standard error of ± 1%. 
ROS producers 
DDC 
The data in Figure 2e shows the MTT assay performed on U937 to assess cell viability 
following a 3hr treatment. A concentration range of (0-400) μM was used. Following a 
literature review and data obtained from the MTT assay, the doses of DDC chosen for 
treatment were 25 μM, 50 μM and 100 μM (Dumay et al., 2006; Kimoto-Kinoshita et al., 
2004). At 25 μM the percentage cell viability was approximately 120% with a standard error 
± 10%. Similarly at 50 μM and 100 μM the percentage cell viability was approximately 
110% ±12% and 140% respectively. 
H2O2 
The data in Figure 2f shows the MTT assay performed on U937 to assess cell viability 
following a 3hr treatment of H2O2. A concentration range of (0-1000) μM was used. 
Following the literature review and data obtained from the MTT assay, the doses of H2O2 
chosen for treatment were 50μM, 100μM and 200μM (Ahmad et al., 2004). At the 




The data in Figure 2g shows the MTT assay on U937 to assess cell viability following a 3hr 
treatment of SIN-1 chloride. A concentration range of (0-1000) μM was used. Following a 
literature review and data obtained from the MTT assay, the doses of SIN-1 chloride chosen 
for treatment were 250 μM, 500 μM and 1 mM (Oliveira et al., 2003). At the concentration 
range of between 250 μM-1 mM the percentage cell viability was approximately 100%. 
 
DETA-NO 
The data in Figure 2h shows the MTT assay on U937 to assess cell viability following a 3hr 
treatment of DETA-NO. A concentration range of (0-1000) μM was used. Following a 
literature review and data obtained from the MTT assay, the doses of SIN-1 chloride chosen 
for treatment were 250 μM, 500 μM and 1 mM (Oliveira et al., 2003).  At 250 μM the 
percentage cell viability was approximately 100% ± 15%. Similarly at 500μM and 1mM the 






Part II) Resveratrol induces NOX5 expression in U937 
 
























Figure 3: Analysis of NOX5 expression following 24hr of RSV treatment  
a) A representative western blot analysis of NOX5 expression.U937 cells were subjected 
to 24hr of RSV treatment at the respective doses. Whole cell lysates were then 
subjected to western blotting to determine the NOX5 expression level.  
b) A quantitative analysis of NOX5 expression level 
Error bars represent ±S.D. Number of independent experiments (n=3) 
 
  * - Indicates p<0.05,( student’s t-test) 
 
 Positive control:[PMA]- 10 ng/ml  





Time course for basal level of NOX5 expression 
a) 


















Figure 4: Basal expression level of NOX5 in untreated U937 cells  
a) A representative western blot analysis of NOX5 expression. The basal level of NOX5 in 
untreated/control U937 cells were monitored over time. The whole cell lysates obtained at 
each indicated time point were subjected to western blot analysis. 
c) A quantitative analysis of NOX5 expression. Error bars represent ±S.D. Number of 
independent experiments (n=2) 
 


































Figure 5: A time course study of NOX5 expression in U937 following 
25 μM Resveratrol treatment 
 
a) A representative western blot analysis of NOX5 expression. U937 cells were subjected to 
25 μM RSV treatment at the indicated time points of 0hr, 2hr, 4hr, 6hr, 8hr 16hr and 
24hr. Whole cell lysates were then subjected to western blotting to determine the NOX5 
expression level. 
b) A quantitative analysis of NOX5 expression level. Error bars represent ±S.D. Number of 
independent experiments (n=2) 
 
  * - Indicates p<0.05,( student’s t-test) 
 
Positive control:[PMA]- 10 ng/ml  


































[RSV]    
 Figure 6: Analysis of NOX5 expression following 3hr of Resveratrol treatment  
a) A representative western blot analysis of NOX5 expression.U937 cells were 
subjected to 3hr of RSV treatment at the respective doses. Whole cell lysates were 
then subjected to western blotting to determine the NOX5 expression level. 
b) A quantitative analysis of NOX5 expression level 
 
Error bars represent ±S.D. Number of independent experiments (n=2) 
 
  * - Indicates p<0.05, (student’s t-test) 
 
Positive control:[PMA]- 10 ng/ml  
















RSV increases NOX5 expression level 
 
Having established the physiological effects of RSV in a dose-dependent manner the next 
question to be addressed was the level of NOX5 expression. This was essential so as to draw 
a link between the NOX5 expression level and effects of the various RSV doses. Thus a 24hr 
RSV treatment was performed to study the NOX5 expression status. The western blot in 
Figure 3 shows the NOX5 expression following 24hr RSV treatment at the various indicated 
doses. The western blot shows that a significant increase in NOX5 expression can be 
observed following 16 μM and 33 μM of RSV treatment. The densitometry analysis in Figure 
3b shows an estimated 3-fold increase in NOX5 expression level in comparison to the 
control/untreated cells. At the concentrations of 4 μM and 8 μM no significant increase in 
NOX5 expression level was observed. U937 treatment with10 ng/ml of PMA was used as a 
positive control. It has been shown in previous studies that PMA activates NOX5. DMSO 
treatment was used as a vehicle/negative control for RSV. The concentration of DMSO used 
was 0.0025% and the treatment showed no significant change in the level of NOX5 
expression.  
 
It was also prudent to understand the time kinetics of NOX5 expression. Thus, to study how 
early NOX5 expression increases in the U937 system, a time course was performed. The 
basal NOX5 expression level of untreated U937 was monitored over time. The western blot 
in Figure 4 shows the NOX5 expression level in untreated U937 cells at the various indicated 
time points of 0 hr,2 hr, 4 hr, 6 hr, 8 hr, 16 hr and 24 hr. The western blot shows no 
significant change in the NOX5 expression level. A slight increase in NOX5 expression was 
observed at 6hr. The expression of NOX5 then decreased. After conferring with the cell 
viability, cell cycle profile and 24hr RSV treatment western blot data, the dose chosen for 
subsequent treatments, was 25μM RSV. The time points chosen for the time course were 0 
hr, 2hr, 4hr, 6hr, 8hr, 16hr and 24hr.  From Figure 5a the western blot analysis shows the 
general trend that NOX5 expression increases from 2hr to 6hr. NOX5 expression seems to 
peak between 6-8hr. Following that NOX5 expression level begins to decrease. However at 
24 hr, NOX5 level still remains significantly higher compared to the untreated cells albeit not 
the maximum expression level. 
 
The densitometry analysis in Figure 5b translates the data in a quantitative manner. At 2 hr 





untreated cells. A maximal increase of 4-fold in NOX5 expression level was observed at 6hr 
in comparison to control. A decrease in NOX5 expression level was observed from 8hr-24hr. 
The NOX5 expression level decreased from 3 to 2- fold relative to the untreated cells 
between 8hr-24hr. At 24hr, NOX5 expression level in RSV treated cells still remained 
significantly higher than the control cells. 
 
From the time course it is thus evident that NOX5 expression begins to increase between the 
time frame of (2- 4) hr. Thus a time point of 3hr and dose of 25 μM was chosen for 
subsequent experiments on U937 cells. The western blot analysis in Figure 6 studies the 
expression level of NOX5 following 3hr RSV treatment at the indicated doses. The western 
blot shows that 25 μM and 50 μM RSV are able to increase NOX5 protein levels at 3hr. The 
densitometry analysis indicates a 1.5 fold and 2 fold increase at 25 μM and 50 μM RSV 
respectively relative to the untreated cells. 
 
Part III) RSV induced increase in NOX5 expression is regulated via ROS production 
 















































        
 









Figure 7a: ROS production in U937 cells DCFDA assay was performed to measure the 
level of ROS produced following RSV treatment. The percentage of cells in R2 region is a 
measure of the fluorescence intensity  
 
(i) 12hr time point 






















 b) Scavenging of ROS and inhibition of NOX activity abrogates the increase in the 

















DMSO (0.0025%)          +       -       -        -       -        -       -        -      -         -        -         - 
PMA 10 ng/ml                 -       +       -        -       -        -       -        -      -         -        -         - 
RSV 25 μM                      -        -       -       +        -       +      -        +     -        +        -         +  
Tiron 3 mM                     -        -       -        -       +       +       -       -      -         -        -         -  
NAC 20 mM                    -        -       -        -        -        -      +       +     -         -        -         - 
Catalase 1000 U/ml        -       -       -         -        -        -       -       -     +        +        -         - 











Figure 7b: Pre-incubation of U937 with ROS scavengers and NOX inhibitor DPI abrogates the 
increase in Nox5 expression following 25μM RSV treatment 
 
i) A representative western blot analysis of NOX5 expression (N=2).U937 cells were pre- 
incubated with either of the following i) 3 mM Tiron ii) 20 mM NAC iii) 1000U/ml Catalase  iv) 2.5 
μM DPI for 1hr. The cells were then treated with 25μM RSV for 3hr. Whole cell lysates were used 
for western blotting to determine the expression level of NOX5. 
 
ii) Quantitative analysis of NOX5 expression level. Error bars represent ± S.D. Number of 
independent experiments (n=2) 
 





It is well established that RSV modulates cellular redox status. The ROS levels in U937 cells 
were analyzed following 12hr of RSV treatment via the DCFDA assay using the LSC. A 12 
hr time point was chosen to relate the ROS levels to the cell cycle profile of U937 as it is 
known that ROS regulates cell cycle. The previous figure has shown that at 12hr, RSV is able 
to cause a S-G2/M phase arrest. The percentage of cells in the R2 region was quantified and 
shown in Figure 7a. From the figure it can be observed that the ROS levels are higher in 
RSV treated cells in comparison to the untreated cells. In addition there was a dose-
dependent increase from 3% (0.78 μM RSV) to 91% (25 μM RSV). The positive control 10 
ng/ml PMA treatment showed a significant increase from 2% to 89% in the R2 region 
following. Having shown that, NOX5 expression level increases by 3hr in response to RSV 
treatment, early time points of 30 minutes, 1hr and 2hr were chosen to assess the ROS levels 
in U937 cells. Figure 7a (ii) shows the DCFDA data following RSV treatment at these 
various time points. At 30 minutes, a significant increase in the percentage of cells in the R2 
region at 50 μM RSV was observed. At 1 and 2 hr a dose-dependent increase in the 
percentage of cells in the R2 region was observed. The histograms are shown in 
supplementary figures 2a-c. The next aim of the study was to investigate the mechanism by 
which RSV regulates NOX5 expression. Having shown that RSV produces ROS in Figure 
7a, it was essential to study if ROS could be involved in the regulation of NOX5 expression. 
The effect of ROS scavenging on the expression level of NOX5 was studied via pre-
incubation of U937 cells with a range of ROS scavengers; tiron (superoxide scavenger), 
catalase (enzyme that catalyzes the conversion of hydrogen peroxide to water and oxygen), 
NAC (It serves a precursor in glutathione formation. The thiol groups are involved in the 
scavenging of free radicals) and DPI (a NOX inhibitor). The cells were pre-incubated with 
the respective doses for 1hr prior to treatment with RSV for 3hr. A western blot analysis was 
then performed to study the expression level of NOX5. From the Figure 7b it was observed 
that the pre-treatment with ROS scavengers and DPI abrogated the increase in NOX5 
expression produced by RSV. A 2-fold increase in NOX5 expression was observed following 
a 10 ng/ml PMA treatment relative to the untreated cells. PMA was used throughout as a 
standard positive control for relative comparison of NOX5 expression following 25 μM RSV 
treatment. Similarly, a 1.5 fold increase in NOX5 expression was observed following 25μM 
RSV treatment. DMSO-treated U937 cells that serve as vehicle control for RSV showed no 
significant change in NOX5 level relative to the untreated cells.  Pre-treatment of U937 cells 
with the respective ROS scavengers did not significantly alter the NOX5 expression levels. 





scavengers and DPI, the 3hr co-treatment with 25 μM RSV did not cause a significant 
increase in comparison to the cells treated with RSV only. The NOX5 expression levels were 
comparable to that of the untreated cells. This data suggests that scavenging of ROS 
abrogates the increase in NOX5 levels. This strongly hints that ROS is an upstream factor 
involved in the regulation of NOX5 expression. 
 
The protein expression levels of the antioxidant enzymes Cu/ZnSOD, MnSOD and catalase 
were assessed. This is because it has been shown that alteration in cellular redox status affects 
the expression levels of antioxidant systems. Though there is a broad range of antioxidant 
enzymes present, these few were chosen. The western blot analysis in Figure 8 shows no 
significant change in the levels of Cu/ZnSOD, MnSOD and catalase. 
Protein expression levels of the antioxidant enzyme systems remain unchanged (no 
significant change 
                           a)                 






























 Figure 8: RSV treatment does not significantly alter the antioxidant enzyme levels  a) A representative western blot analysis of the antioxidant enzyme levels. (N=3). 
U937 cells were pre- incubated with either of the following i) 3 mM Tiron ii) 20 mM NAC iii) 
1000 U/ml Catalase  iv) 2.5 mM DPI for 1hr. The cells were then treated with 25 μM RSV for 
3hr. Whole cell lysates were used for western blotting to determine the expression level of 
MnSOD, Cu/ZnSOD and Catalase.  
 
b) Quantitative analysis showing the expression level of MnSOD, Cu/ZnSOD and 










The earlier data strongly suggests that ROS is involved in the increase in NOX5 expression. 
To further build on this current hypothesis/premise, ROS producing compounds such as 
DDC, H2O2, SIN-1 chloride and DETA-NO were chosen to study the effect of NOX5 
expression level in U937. These compounds were also chosen as they generate different types 
of ROS species. Thus, another aim was to also investigate the type of ROS species involved 
in regulating NOX5 expression. Basically 3 types of ROS species were being studied; O2.-, 
H2O2 and NO. DDC (an inhibitor of SODs) generates O2.- via inhibiting the enzymatic action 
of SODs. SIN-1 chloride and DETA-NO generate nitric oxide (NO). The U937 cells were 
treated for 3hr with the ROS producing compounds. Following the treatment whole cell 
lysates were harvested and subjected to western blot analysis to study the NOX5 expression 
level. 
In Figure 9, the western blot data shows that DDC significantly increases NOX5 expression. 
This was observed following 25 μM, 50 μM and 100 μM DDC treatment. From the 
densitometry analysis in Figure 9b, a 55% and 33% increase in NOX5 expression relative to 
the control cells was observed with 50 μM and 100 μM DDC treatment respectively. To 
further build on this evidence, U937 cells were pre-incubated for 1 hour with 3mM tiron prior 
to 3hr DDC treatment and the NOX5 expression level was then analyzed via western blot. 
The western blot in Figure 10 shows that pre-incubation with tiron is able to significantly 
reduce the level of NOX5 expression following DDC treatment. From Figure 10b, the 
densitometry analysis showed a 1.5 to 4- fold increase in NOX5 expression following DDC 
treatment relative to the control cells. However in U937 cells pre-treated with 3 mM tiron and 
treated with DDC, only a fold increase was observed. Thus, pre-treatment with tiron reduced 
the NOX5 expression level by approximately 50% in comparison. The treatment with 3 mM 
tiron only did not alter the NOX5 expression relative to the control. Hence the data shows 





addition, that scavenging of ROS via tiron treatment reduces the extent of increase in NOX5 
expression by DDC treatment. 
The data in Figure 11 shows the effect of H2O2 treatment on the NOX5 expression levels in 
U937 cells. From the western blot in Figure 11a the data shows that H2O2 increase NOX5 
expression in a dose-dependent manner.  From the densitometry analysis in Figure 11b a 
significant 2 to 3-fold increase in NOX5 expression level was obtained in response to the 
various doses of H2O2 treatment (50 μM, 100 μM and 200 μM) relative to the control cells. In 
order to show that this trend holds true due to the effect of H2O2, the level of NOX5 
expression was studied via ROS scavenging. U937 cells were pre-treated with either 1000 
U/ml catalase or 3mM tiron for 1hr prior to 3hr H2O2 treatment. The western blot data in 
Figure 12 shows that pre-treatment of U937 with catalase but not tiron abrogates the increase 
in NOX5 expression. This data suggests that H2O2 regulates NOX5 expression.  
DCFDA assay was performed to measure ROS levels following DDC and H2O2 treatment 
and scavenging with tiron and catalase. This was to ensure that the effects of these 
compounds on the NOX5 expression level are due to the ROS modulating abilities and not 
side effects.  The data is shown in the supplementary figures 3 and 4. 
Having shown data that suggest, H2O2 and O2.- regulate NOX5 expression, we aimed to study 
if nitric oxide compounds are also able to produce similar effects. Thus U937 cells were 
subjected to 3hr treatment of SIN-1 chloride and DETA-NO at 3 different doses (250 μM, 
500 μM and 1 mM). The whole cell lysates were harvested and analyzed via western blot. 
The western blot data in Figure 13 showed no significant change in the NOX5 expression 
level following treatment with the compounds. This data suggests that NO is not involved in 
the regulation of NOX5 expression. To ensure that this was not due to possibility that the 
compounds were not working, the phosphorylation status of c-Raf was studied via western 
blotting. Studies have shown that NO compounds regulate the cyclic GMP/Ras/Raf protein 
signaling pathway. Thus c-Raf was used as a positive control. From the western blot shown 
in Figure 13, it was observed that SIN-1 and DETA increase the expression level of phospho 
c-Raf in a dose-dependent manner. This further supported the evidence that, NO-producing 









Part III) ROS producing compounds are able to upregulate NOX5 expression in U937 
 
DDC (an inhibitor of superoxide dismutase) increases NOX5 expression 
 












Figure 9: DDC treatment increases NOX5 expression in U937 cells  
a) A representative western blot analysis of NOX5 expression (N=3). U937 
cells were treated with the indicated doses of DDC for 3hr. Whole cell 
lysates were then harvested for western blot analysis. 
b) Quantitative analysis of NOX5 expression. Error bars represent ±S.D. 
Number of independent experiments (n=3) 
 


































Figure 10: Pre-incubation with Tiron abrogates the increase in NOX5 expression via DDC 
treatment 
a) A representative western blot analysis (N=2) U937 cells were pre-incubated with 3mM of Tiron. 
Following the pre-treatment the cells were then subjected to a 3hr treatment of the respective doses 
of DDC. Whole cell lysates were then harvested and subjected to western blot analysis to 
determine the expression level of NOX5. 
b) A quantitative analysis of NOX5 expression. Error bars represent ±S.D. Number of independent 
experiments (n=3) 
 








H2O2 increases NOX5 expression 
a) 










      [H2O2] 
 Figure 11: H2O2 treatment increases NOX5 expression in U937 
a) A representative western blot analysis of NOX5 expression.(N=3) U937 cells 
were treated with the respective doses of H2O2 for 3hr. Whole cell lysates were 
then harvested and subjected to western blot analysis. 
 
b) A quantitative analysis of NOX5 expression. Error bars represent ± S.D. Number 
of independent experiments (n=3) 
 
* - Indicates p<0.05, (student’s t-test) 
[PMA]:10ng/ml 






























Figure 12: Pre-incubation with Catalase abrogates the increase in NOX5 expression via H2O2 
treatment 
a) A representative western blot analysis (N=2) U937 cells were pre-incubated with 1000 U/ml 
of Catalase. Following the pre-treatment the cells were then subjected to a 3hr treatment of the 
100 μM  of H2O2. Whole cell lysates were then harvested and subjected to western blot analysis 
to determine the expression level of NOX5. 
b) A quantitative analysis of NOX5 expression. Error bars represent ±S.D. Number of 
independent experiments (n=3) 
 
































Figure 13: Nitric oxide producing compounds such as SIN-1 chloride and DETA-NO do 
not significantly change the expression level of NOX5 
a) A representative western blot analysis of NOX5 expression (N=3) 
U937 cells were subjected to a 3hr treatment of the respective doses o SIN-1 and 
DETA. Whole cell lysates were then harvested and subjected to western blot 
analysis. Phospho c-Raf protein expression status was used as a control to ensure 
that the compounds were working.  
      b)  I) Quantitative analysis of phospho c-raf protein expression level Error bars 
represent ±S.D. Number of independent experiments (n=2).  
       II) Quantitative analysis of phospho NOX5 protein expression level. Error bars 











Part IV) RSV treatment leads to CREB phoshorylation 
Previous research has already identified CREB as a transcription factor involved in the 
regulation of NOX5- S (short isoform) expression in esophageal adenocarcinoma (EA). 
CREB is a well-known ROS-regulated transcription factor. Thus the question that was to be 
addressed was if CREB is involved in the regulation of NOX5 expression in U937 cells. The 
phosphorylation status of CREB was studied as a measure of its activity status. U937 cells 





As a positive control for relative comparison of CREB phosphorylation, U937 cells were 
treated with 10 ng/ml of PMA for 1hr. DMSO was used as a negative/vehicle control for 
RSV. The whole cell lysates were harvested and subjected to western blotting to analyze the 
phosphorylation status of CREB and NOX5 expression level. From the western blot in Figure 
14 a time-dependent increase in the phosphorylation of CREB was observed. The 
densitometry analysis in Figure 14b showed a 70% increase in the phosphorylation of CREB 
relative to the control cells at 1hr. Similarly a 1.5-fold increase in CREB phosphorylation 
relative to the control cells was observed at 3hr. In terms of the expression level of NOX5 
from Figure 14, no significant change in was observed at the early time points of 0hr, 15min 
and 30 min. From the densitometry analysis in Figure 14b a 2-fold increase in NOX5 
expression level relative to the control cells was observed at 3hr.  To further build on the 
evidence that CREB phosphorylation is involved in the ROS-mediated regulation of NOX5 
expression, cyclosporin A (an inhibitor of CREB) treatment was used to study the expression 
level of NOX5 and the phosphorylation status of CREB. U937 cells were pre-incubated with 
5 μM and 10 μM of cyclosporin A for 1hr prior to a 3hr 25μM RSV treatment. The western 
blot in Figure 15a shows that cyclosporin A pre-treatment is able to abrogate the 
phosphorylation of CREB. The phosphorylation status can also be linked to the expression 
level of NOX5. In Figure 15a the western blot shows that the increase in NOX5 expression 
level is abrogated by the pre-treatment of cyclosporin A followed by RSV treatment. The 
preliminary data in Figures 14 and 15 suggest that CREB activation is involved in the ROS- 
mediated regulation of NOX5 expression. The doses of 5 μM and 10 μM were chosen 
following a literature search (Garcia et al., 2000; García et al., 1999). In addition the data 


























































Figure 14: RSV treatment results in the phosphorylation of CREB in a time-dependent 
epresentative western blot analysis (n=2) 
t for the respective time points of 
 I) Quantitative analysis of phospho-CREB. Error bars represent ±S.D. Number 






U937 cells were subjected to 25 μM RSV treatmen
0hr, 15min, 30 min, 1hr and 3hr. Whole cell lysates were then harvested and 
subjected to western blot analysis. The NOX5 expression level and CREB 
phosphorylation status were analyzed. 
 
b)
of experiments (n=2) 
c) II) Quantitative analys
of experiments (n=2) 












   
 
 








































Figure 15: Pre-treatment of Cyclosporin A inhibits the phosphorylation of CREB and 
abrogates the increase in NOX5 expression observed via RSV treatment. 
a) A representative western blot analysis of the CREB phosphorylation status and NOX5 
expression level (N=2). U937 cells were pre-treated with either 5 μM or 10 μM of 
cyclosporin A for 1hr. Following the pre-incubation, the cells were subjected to 25 
μM RSV treatment for 3hr. Whole cell lysates were then harvested and subjected to 
western blot analysis. 
b)  I) Quantitative analysis of NOX5 expression level. 
Error bars represent ± S.D. Number of independent experiments (n=2) 
c)      II) Quantitative analysis of phospho-CREB expression level. 
Error bars represent ± S.D. Number of independent experiments (n=2) 
 
 
Positive control:[PMA]- 10 ng/ml  
Negative control: [DMSO]- 0.0025% 
 
 












4.1: Overview on the study 
The NOX family comprises of 7 family members; NOX 1-5 and DUOX1/2 (Bedard and 
Krause, 2007; Lambeth et al., 2007). NOXs are a group of enzymes involved in the 
generation of O2.- ions. This takes place via the electron transfer during the reduction of 
NADP+ to NADPH. Oxygen serves as the electron acceptor thus leading to the formation of 
O2.- ions (D'Autréaux and Toledano, 2007; Halliwell, 2007). This then leads to the 
progressive formation of the various forms of ROS. NOX is one of the major enzyme systems 
involved in the production of ROS. The early research on NOX led to the discovery of NOX2 
or phagocytic oxidase. NOX2 was characterized in immune cells such as phagocytes and 
neutrophils to playing a role in innate immune system. ROS generated via NOX2 was 
deemed harmful and involved in killing microbial organisms. However a paradigm shift led 
to discovery of NOX isoforms in non-immune cells. Furthermore, the ROS produced was 
shown to be physiologically relevant and crucial in the activation of signal transduction 
pathways. Currently ROS is widely perceived as secondary messengers/ signalling molecules, 
that play an important role in maintaining cell function and physiology (Brown and 
Griendling, 2009; D'Autréaux and Toledano, 2007). Furthermore, a homeostatic balance in 
the cellular redox status is essential in normal cellular function. An upset in the balance of 
ROS triggers ‘oxidative stress’ in the cell and alters cell signalling fate and the resulting 
physiology of the cell (Pervaiz and Clement, 2007). The balance in the type of ROS species 
is also crucial in determining the signalling pathways activated. It is well established that 
NOX-derived ROS plays a major role in mediating the activation of various signal 
transduction pathways involved in cell survival/proliferation and cell death. In conjunction 
with regulating these 2 pathways, NOXs have also been highlighted to control tumour 
initiation and progression (Kamata, 2009). In addition, the role of NOX has also been studied 
in the inflammation and immune system (Kamiguti et al., 2005; Park et al., 2006; Park et al., 
2004). 
NOX5 is a novel member of the NOX family. It has a different mode of activation in 
comparison to its counterparts (Fulton, 2009). NOX5 does not require the assembly of 





cytosolic Ca2+ concentration and kinase-mediated phosphorylation (Bánfi et al., 2001; Bánfi 
et al., 2004; Serrander et al., 2007). 
RSV, a phenolic phytoalexin, is currently being explored as a 
chemotherapeutic/chemopreventive drug (Holme and Pervaiz, 2007; Pervaiz, 2004; Pervaiz 
and Holme, 2009). It has the unique ability of modulating intracellular ROS levels (Ahmad et 
al., 2004; Low et al., 2010). This has been shown to be concentration and cell line dependent. 
This study aimed to study the involvement of RSV as a ROS modulating drug in the 
expression level of NOX5 in the hematopoietic system U937. This is based on the 
premise/observation that RSV has been shown to regulate NOX activity in human leukemia 
cells and elicit cardioprotective effects in vascular cells via altering NOX-mediated ROS 
levels (Ahmad et al., 2004; Carluccio et al., 2007; Pervaiz, 2004). 
4.2: RSV exerts several physiological effects in a dose-dependent manner in U937 
The MTT cell viability assay was performed to determine the dose-dependent effect of RSV 
on U937 cells. As shown by the data in Figure 1, RSV exerts several physiological effects on 
U937. This evidence correlates with other published data. 
Summary of RSV’s physiological effects  in U937 and other myeloid cell lines 
1. RSV treatment at relatively high concentrations of 60 μM to 120 μM led to apoptosis 
in U937 cells (Park et al., 2001b) The data also highlighted that the overexpression of 
anti-apoptotic protein Bcl2 in the system rescues the cells from RSV-induced 
apoptosis in U937. 
2. RSV causes an S to G2/M phase arrest in U937 cells (Park et al., 2001a).  
3. Low concentrations of RSV promote cell survival in human leukaemia cell lines HL-
60 and CEM. RSV was shown to inhibit ROS-mediated drug induced apoptosis 
(Ahmad et al., 2004). 
4.3: RSV treatment increases NOX5 expression level in U937 
Using western blotting analysis, the results have shown that RSV is able to cause a dose-
dependent increase in NOX5 expression level in U937 cells. This was observed at 3hr and 





dose of 25 μM RSV to study the profile of NOX5 expression level. One shortcoming would 
be the lack of data to show that this effect of RSV is exclusive to NOX5 and does not affect 
the other NOX isoforms present in U937. Western blotting to analyze the expression level 
various NOX isoforms was performed but the data was not shown. This was due to further 
optimization needed for the various antibodies (Bedard and Krause, 2007). However, the 
study by Krause et.al has shown that in DU145, NOX1 and NOX5 are the major isoforms 
present. The data showed that the cell survival and proliferation was only affected via 
silencing of NOX5 but not NOX1 (Brar et al., 2003). In human endothelial cells, angiotensin 
II treatment was shown to increase NOX5 expression in a time-dependent manner however 
NOX4 levels remained unchanged (Park et al., 2006). Thus there is strong evidence from 
previous studies that NOX5 isoform can be specifically regulated by agonists/triggers.  
This data supports previous studies that NOX5 levels can be regulated at the protein 
expression level. NOX5-S expression was studied to be regulated by factors such as platelet-
derived growth factor (PDGF) and platelet activating factor (PAF). This was shown to be 
crucial in the development of adenocarcinoma (Fu et al., 2006; Si et al., 2008; Si et al., 
2007). A study by Touyz et.al., has shown that NOX5 activity and expression can be 
regulated via angiotensin (Ang) II and endothelin (ET)-1 in Human endothelial cells 
(Montezano et al., 2010). 
In the western bots, NOX5 migrated as a doublet. This occurrence has also been observed in 
a study on NOX4 (von Löhneysen et al., 2008). Though the occurrence is unexplainable it is 
known that NOXs undergo post-translational modifications such as glycosylation and 
phosphorylation (Fulton, 2009). It would be of future interest to further analyze the doublets 
via protein analysis tools such as mass spectrometry.  
4.4: i) RSV produces ROS 
       ii) Treatment with ROS scavengers abrogates the increase in NOX5 expression 
Having shown that RSV increases NOX5 expression in U937, the factor(s) regulating its 
expression was studied. ROS was believed to be involved in this system due to the nature of 
RSV. Furthermore NOX1 and 4 isoforms have been shown to be regulated via RSV (Schilder 
et al., 2009). Thus to investigate this hypothesis, U937 cells were pre-treated with ROS 





results showed that scavenging ROS abrogated the increase in NOX5 expression. This 
corroborates with previous studies that RSV modulates the cellular ROS levels. 
iii) The antioxidant enzyme levels are not altered significantly following RSV treatment 
The antioxidant enzyme systems play an important role in maintaining cellular redox balance 
by countering the production of ROS. It has been studied that the expression and/or activity 
levels of antioxidant enzymes are altered in response to oxidative stress. In a study by 
G.Spanier et.al it was shown that in human endothelial cells, 24hr RSV treatment decreases 
the expression of NOX4. This was shown to relate to a decrease in SOD 1 levels and 
Glutathione peroxidase 1 (GpX1) was observed after RSV treatment (Spanier et al., 2009). 
In addition to ROS modulation altering the antioxidant enzyme status, the converse has also 
been studied in previous studies. Mutations or dysfunctioning of the antioxidant enzymes can 
also regulate the cellular ROS levels and lead to an imbalance in the redox status. Though the 
data in the study showed that regulating the level of ROS in the cells does not significantly 
change the expression of the antioxidant enzymes such as Cu/ZnSOD, MnSOD and catalase, 
it is not conclusive as only one time point was assessed. The involvement of antioxidant 
systems in regulating the expression of NOX5 could also have been further established by 
performing overexpression and knockdown studies. Functional studies would also strengthen 
the data and provide better understanding regarding the role of antioxidant enzymes in this 
system. 
4.5: i) ROS producing compounds such as DDC and Hydrogen Peroxide (H2O2) cause 
an increase in NOX5 expression. 
       ii) ROS scavenging abrogates the increase in NOX5 expression 
Having shown the data that ROS is a possible factor in the regulation of NOX5 in U937, 
further investigation was essential to strengthen the preliminary evidence. Thus the effect of 
ROS producing compounds on NOX5 expression level was studied. As shown in the results 
section, O2.- generating compound DDC was able to increase NOX5 expression in a dose-
dependent manner at level at low concentrations. This effect was shown to be reversible by 
ROS scavenging via tiron. Similarly H2O2 was also able to showcase the same effect. The 





have not shown ROS to be an upstream mediator/factor regulating NOX5 expression. Thus 
this is a novel piece of evidence 
      iii) NO-producing compounds to not change the expression level of NOX5  
The data in the results section showed that NO-producing compounds such as SIN-1 chloride 
and DETA-NO did not change the levels of NOX5 unlike DDC and H2O2. This suggested 
that the ROS species involved in regulating NOX5 expression could be specific to O2.- ions 
and/or H2O2. The phosphorylation status of phospho c-Raf was studied as a positive control 
for the nitric oxide compounds. It has been shown that NO- producing compounds activate c-
Raf via the cGMP pathway (Oliveira et al., 2003). However a greiss reaction assay to 
quantify the level of nitric acid produced would have added further support to the evidence. 
4.6: i) RSV treatment leads to the phosphorylation of CREB 
A previous study has showed that NOX5-S expression is regulated via CREB in esopheageal 
cells (Fu et al., 2006) as the promoter sequence of NOX5-S was analyzed to have 2 CRE 
response elements. This highlighted the possibility that CREB is a transcription factor 
regulating the NOX5 expression. Thus, it was interesting to investigate if RSV induces the 
activation of CREB which in turn is involved in upregulating the expression level of NOX5. 
The data showed that RSV was able to phosphorylate CREB at an early time point of within 
an hour. This also showed that the phosphorylation of CREB preceded the increase in NOX5 
expression level. A missing element in this data to support this evidence was the assay to 
show CREB activation following RSV treatment. This could have been done via silencing of 
CREB and/or transfection of the dominant-negative form of CREB (A-CREB). It is well 
characterized that CREB is a ROS regulated transcription factor and RSV activates CREB. 
The new evidence from this data, that the phosphorylation status correlates with NOX5 
expression level suggests that CREB is a possible transcription factor.  







ii) The inhibition of CREB phosphorylation via pre-treatment with Cyclosporin A 
abrogates the increase in NOX5 expression level. 
Inhibitory study was performed using Cyclosporin A to further support the evidence that 
RSV is involved in the phosphorylation of CREB. Cyclosporin A works by, altering the 
mitochondrial potential that inhibits Ca2+ flux and the subsequent activation of PKC which 
leads to the phosphorylation of CREB. The treatment with Cyclosporin A prevented the 
increase in NOX5 expression. Furthermore the increase in NOX5 expression was also 
abrogated via pre-treatment with Cyclosporin A. This data suggests that RSV mediated 
increase in NOX5 expression could potentially be via CREB. 
4.7: Conclusion 
Previous studies have highlighted NOX5 as a growth signaling oxidase. Thus it has been 
shown to regulate cell survival and death in tumor cell lines. NOX5 has been shown to be 
highly expressed in lymphoid tissue but absent/ lowly expressed in circulating lymphocytes 
such as U937 cells. This study shows how a ROS modulating compound such as Resveratrol 
is able to alter the expression level of NOX5 in the background of a lymphoma cell line 
U937. The study has shown that RSV is able to cause an increase in the expression level of 
NOX5 in a dose and time dependent manner. The increase in NOX5 level was shown to be 
mediated by ROS produced via RSV. The scavenging of RSV-produced ROS was able to 
abrogate the increase in NOX5 expression. This hypothesis was further strengthened by 
showing that addition of ROS producing compounds such as DDC and H2O2 were able to 
cause an increase in NOX5 expression level, while NO-producing compounds did not 
significantly alter the levels of NOX5. The main antioxidant enzyme levels remained 
unchanged with following RSV treatment. The data also showed that RSV phosphorylates 
CREB before the increase in NOX5 expression. The addition of cyclosporin A causes a 
decrease in the level of NOX5 expression and inhibits CREB phosphorylation. Thus this 
highlights the possibility of CREB being a transcription factor regulating NOX5 expression 
as seen in studies involving the NOX5-S isoform. The diagram in Figure 1 summarises the 



















Figure 1: Diagram representing the summary of the study 
(i)       The illustration highlights the data obtained that, RSV causes the phosphorylation of 
CREB which then leads to the increase in NOX5 expression. Cyclosporin A was able to 
inhibit the phosphrylation of CREB and decreased the NOX5 expression level. 
(ii)       The illustration highlights the data obtained that ROS-producing compounds such as 
RSV/DDC/H2O2 are able to cause an increase in NOX5 expression level. Furthermore, 











4.8: Future work 
Based on the novel findings from this project the future work will address: 
1. The initial part of this study focused on how RSV, a drug is able to regulate the 
expression level of NOX5 in U937 cells. This can be further extended to study the 
involvement of other ROS producing/modulating chemotherapeutic drugs in 
regulating NOX5 activity and expression. Such drugs include Cisplatin, Doxorubicin, 
Docetaxel, Paclitaxel and Daunorubicin. Furthermore in addition to using various 
chemotherapeutic drugs the research can be widened by using different tumor cell 
lines of variable NOX5 expression.  
 
2. The main crux of the data that involves protein expression levels of NOX5 can be 
further validated with semi-quantitative or real-time PCR data. Data showing mRNA 
levels of treatment with RSV would further strengthen the hypothesis that RSV 
regulates NOX5 expression. This would show or suggest if NOX5 is regulated at the 
transcriptional and/or translational level. This can be further explored by performing 
inhibitory studies using Actinomycin D (ActD) and Cyclohexamide (CHX). ActD is 
an inhibitor of transcription. The mode of action, involves the binding of ActD to 
DNA at the transcription initiation complex and prevent elongation by RNA 
polymerase.  CHX inhibits protein biosynthesis by interfering with the translocation 
step in biosynthesis thus blocking translational elongation. Preliminary experiments  
were performed using ActD and CHX (data not shown). However further 
optimization regarding the concentrations used and the incubation time were needed 
and thus the data was inconclusive. 
 
3. In addition to supporting the data with protein expression and mRNA data, it would 
be prudent to study the activity of NOX5. NOX5 activity is known to be regulated via 
elevation of cytosolic Ca2+ concentration levels. Thus NOX5 activity can be studied 
by performing calcium flux assays or use of Ca2+ chelators such as BAPTA-AM and 
EGTA. The activity would also add another dimension to the study that NOX5 






4. Besides Ca2+ flux, NOX5 is also regulated by phosphorylation at the serine residues. 
Current studies have shown that PKC is involved in the phosphorylation of NOX5 
(Serrander et al., 2007). The phosphorylation status of PKC and other kinases 
(Oliveira et al., 2003)such as p38, Erk, Jnk can be studied. Thus other kinases that 
regulate NOX5 activity and expression can be identified. The current data in this 
study shows that RSV treatment causes the phosphorylation of CREB and regulates 
NOX5 expression. This can be further extended by using bioinformatics tools to study 
the promoter sequence of NOX5. Thus CRE element sequences can be identified to 
further strengthen the data that CREB is a possible transcription factor regulating 
NOX5 expression. The factors that regulate CREB can also be identified to further 
support the evidence. Previous investigations have highlighted that Protein kinase A 
(PKA) and members of the MAP Kinase family are able to activate CREB 
phosphorylation (Shaywitz and Greenberg, 1999). In addition other potential 
transcription factors can be identified via studying the promoter sequence.  
 
Bringing forth the study in this direction would better project NOX5 as a cancer biomarker 
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6. SUPPLEMENTARY FIGURES 
 














Figure 1a: Histograms and scatterplots representing the 12hr U937 cell cycle profile  
The U937 cells were treated with the indicated doses of RSV for 12hrs and the cell cycle 
was analyzed by PI assay using the LSC. The control (untreated) cells are represented in 
red as an overlay in the histograms. 






Figure 1b) PI cell cycle analysis of U937 cells following 24hr of RSV treatment 
 
PMA 10ng/ml RSV 6.25μM RSV 12.5μM RSV 25μM  
    









Figure 1b: Histograms representing the 24hr U937 cell cycle profile  
The U937 cells were treated with the indicated doses of RSV for 24hrs and the cell cycle 
was analyzed by PI assay using the LSC. The control (untreated) cells are represented in 
red as an overlay in the histograms. 











Figure 2a) DCFDA assay analyzing ROS production following 30 minutes of RSV 
treatment in U937 cells 
    









Figure 2a: Histograms representing the ROS production in U937 cells  
The U937 cells were treated with the indicated doses of RSV for 30 minutes and the ROS 
production was analyzed by the DCFDA assay using the LSC. The control (untreated) 
cells are represented in red as an overlay in the histograms. 


































Figure 2b: Histograms representing the ROS production in U937 cells  
The U937 cells were treated with the indicated doses of RSV for 1hr and the ROS 
production was analyzed by the DCFDA assay using the LSC. The control (untreated) 
cells are represented in red as an overlay in the histograms. 











Figure 2c) : DCFDA assay analyzing ROS production following 12hr of RSV treatment 
in U937 cells 
 
  Untreated/control 0.788125μM RSV 1.5625μM RSV 
   
  3.125μM RSV 6.25μM RSV 12.5μM RSV 
    








Figure 2c: Histograms representing the ROS production in U937 cells  
The U937 cells were treated with the indicated doses of RSV for 12hr and the ROS 
production was analyzed by the DCFDA assay using the LSC. The control (untreated) 
cells are represented in green as an overlay in the histograms. 






Figure 3a: DDC produces ROS 
       
17% 12% 27%  
Figure 3a: Histograms representing the ROS production in U937 cells  
The U937 cells were treated with the indicated doses of DDC and the ROS production 
was analyzed by the DCFDA assay using the LSC. The control (untreated) cells are 
represented in blue as an overlay in the histograms. 






Figure 3b: The ROS produced by DDC can be scavenged by tiron 
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Figure 3b: Histograms representing the ROS production in U937 cells  
The U937 cells were pre-incubated with 3mM of tiron for an hour and treated with 
indicated doses of DDC for 1hour .ROS production was analyzed by the DCFDA assay 
using the LSC. The control (untreated) cells are represented in green as an overlay in 
the histograms. 













Figure 4a: H2O2 produces ROS 
      






Figure 4a: Histograms representing the ROS production in U937 cells  
The U937 cells were treated with the indicated doses of H2O2 for 1hr and the ROS 
production was analyzed by the DCFDA assay using the LSC. The control (untreated) 
cells are represented in red as an overlay in the histograms. 
10ng/ml PMA was used as a positive control.  
Figure 4b: ROS produced by H2O2 can be scavenged by catalase  
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10ng/ml PMA was used as a positive control.  
The U937 cells were pre-incubated with 1000U/ml of catalase for an hour and treated 
with indicated doses of DDC for 1hour .ROS production was analyzed by the DCFDA 
assay using the LSC. The control (untreated) cells are represented in blue as an overlay 
in the histograms. 
Figure 4b: Histograms representing the ROS production in U937 cells   
